Publikationen im Kontext des Netzwerks Universitätsmedizin

Im Folgenden finden Sie Publikationslisten aus der ersten Förderphase (NUM 1.0). Publikationslisten aus der zweiten Förderphase (NUM 2.0) des Netzwerks Universitätsmedizin werden sukzessive ergänzt.

Publikationen im NUM 1.0

AKTIN-EZV

Doehn JM, Tabeling C, Biesen R, Saccomanno J, Madlung E, Pappe E, Gabriel F, Kurth F, Meisel C, Corman VM, Hanitsch LG, Treskatsch S, Heim K, Stegemann MS, Ruwwe-Glösenkamp C, Müller-Redetzky HC, Uhrig A, Somasundaram R, Spies C, von Bernuth H, Hofmann J, Drosten C, Suttorp N, Witzenrath M, Sander LE, Hübner RH. CD169/SIGLEC1 is expressed on circulating monocytes in COVID-19 and expression levels are associated with disease severity. Infection. 2021 Aug;49(4):757-762. doi: 10.1007/s15010-021-01606-9. Epub 2021 Apr 6. PMID: 33825125
Greiner T, Boender TS, Greiner F et al., Routinedaten aus der medizinischen Versorgung für die Notaufnahme-Surveillance: 1,5 Jahre Notaufnahme-Situationsreport. Robert Koch-Institut, 2021. DOI 10.25646/9413
Preprint: Boender, TS., Cai, W., Schranz, M. et al., Using routine emergency department data for syndromic surveillance of acute respiratory illness before and during the COVID-19 pandemic in Germany, week 10-2017 and 10-2021. medRxiv 2021.08.19.21262303; doi: doi.org/10.1101/2021.08.19.21262303
Triefenbach, L., Otto, R., Bienzeisler, J. et al., Establishing a data quality baseline in the AKTIN Emergency Department Data Registry – A secondary use perspective, In Print, MIE 2022

B-FAST

Testmethoden

Deckert A, Anders S, de Allegri M, et al. Effectiveness and cost-effectiveness of four different strategies for SARS-CoV-2 surveillance in the general population (CoV-Surv Study): a structured summary of a study protocol for a cluster-randomised, two-factorial controlled trial. Trials 2021; 22(1). https://doi.org/10.1186/s13063-020-04982-z
Deckert A, Anders S, De Allegri M, et al. Effectiveness and cost-effectiveness of four different strategies for SARS-CoV-2 surveillance in the general population (CoV-Surv Study): study protocol for a two-factorial randomized controlled multi-arm trial with cluster sampling. Trials 2021; 22(1). https://doi.org/10.1186/s13063-021-05619-5
Würstle S, Spinner CD, Voit F, et al. Self-sampling versus health care professional-guided swab collection for SARS-CoV-2 testing. Infection 2021; 49(5). https://doi.org/10.1007/s15010-021-01614-9
Würstle S, Erber J, Hanselmann M, et al. A telemedicine-guided self-collection approach for PCR-based SARS-CoV-2 testing: Comparative study. JMIR Form Res 2022; 6(1). https://doi.org/10.2196/32564
Graf S, Engelmann L, Wölfler OJ, et al. Reopening the Bavarian State Opera Safely: Hygiene Strategies and Incidence of COVID-19 in Artistic Staff During Theater Season 2020/2021. J Voice 2021. https://doi.org/10.1016/j.jvoice.2021.11.012
Brümmer LE, Katzenschlager S, Gaeddert M, et al. Accuracy of novel antigen rapid diagnostics for SARS-CoV-2: A living systematic review and meta-analysis. PLOS Med 2021; 18(8). https://doi.org/10.1371/journal.pmed.1003735.
Dao Thi VL, Herbst K, Börner K. et al. A colorimetric RT-LAMP assay and LAMP-sequencing for detecting SARS-CoV-2 RNA in clinical samples. Sci Transl Med 2020; 12(556). https://doi.org/10.1126/scitranslmed.abc7075
Herbst K, Meurer M, Kirrmaier D, et al. Colorimetric RT-LAMP and LAMP-sequencing for Detecting SARS-CoV-2 RNA in Clinical Samples. BIO-Protoc 2021; 11(6). https://doi.org/10.21769/BioProtoc.3964
Krüger LJ, Gaeddert M, Tobian F. et al. The Abbott PanBio WHO emergency use listed, rapid, antigen-detecting point-of-care diagnostic test for SARS-CoV-2—Evaluation of the accuracy and ease-of-use. PLOS ONE 2021; 16(5). https://doi.org/10.1371/journal.pone.0247918
Krüger LJ, Klein JAF, Tobian F, et al. Evaluation of accuracy, exclusivity, limit-of-detection and ease-of-use of LumiraDx™: An antigen-detecting point-of-care device for SARS-CoV-2. Infection 2022; 50. https://doi.org/10.1007/s15010-021-01681-y
Denzler A, Jacobs ML, Witte V, et al. Rapid comparative evaluation of SARS-CoV-2 rapid point-of-care antigen tests. MedRxiv 2021 (preprint). https://doi.org/10.1101/2021.07.29.21261314
Klein JAF, Krüger LJ, Tobian F, et al. Head-to-head performance comparison of self-collected nasal versus professional-collected nasopharyngeal swab for a WHO-listed SARS-CoV-2 antigen-detecting rapid diagnostic test. Med Microbiol Immunol 2021; 210(4), https://doi.org/10.1007/s00430-021-00710-9
Klein S, Müller TG, Khalid D, et al. SARS-CoV-2 RNA extraction using magnetic beads for rapid large-scale testing by RT-qPCR and RT-LAMP, Viruses 2020; 12(8). https://doi.org/10.3390/v12080863
Lee RA, Herigon JC, Benedetti A, et al. Performance of saliva, oropharyngeal swabs, and nasal swabs for SARS-CoV-2 molecular detection: A systematic review and meta-analysis. J Clin Microbiol 2021; 59(5). https://doi.org/10.1128/JCM.02881-20
Ludwig KU, Schmithausen RM, Li D, et al. LAMP-Seq enables sensitive, multiplexed COVID-19 diagnostics using molecular barcoding. Nat Biotechnol 2021; 39(12). https://doi.org/10.1038/s41587-021-00966-9
Nikolai O, Rohardt C, Tobian F, et al. Anterior nasal versus nasal mid-turbinate sampling for a SARS-CoV-2 antigen-detecting rapid test: does localisation or professional collection matter? Infect Dis 2021; 53(12). https://doi.org/10.1080/23744235.2021.1969426
Wachinger J, Olaru ID, Horner S, et al. The potential of SARS-CoV-2 antigen-detection tests in the screening of asymptomatic persons. Clin Microbiol Infect 2021; 27(11). https://doi.org/10.1016/j.cmi.2021.07.020
Wachinger J, Schirmer M, Täuber N, et al. Experiences with opt-in, at-home screening for SARS-CoV-2 at a primary school in Germany: an implementation study. BMJ Paediatr Open 2021; 5(1). https://doi.org/10.1136/bmjpo-2021-001262
Adams ER, Wolday D, Denkinger CM, et al. Scaled testing for COVID-19 needs community involvement. J Glob Health 2021; 11. https://doi.org/10.7189/jogh.11.03033
Peter AS, Roth E, Schulz SR, et al. A pair of noncompeting neutralizing human monoclonal antibodies protecting from disease in a SARS‐CoV‐2 infection model. Eur J Immunol 2021. https://doi.org/10.1002/eji.202149374
Walker A, Houwaart T, Finzer P, et al. Characterization of SARS-CoV-2 genetic structure and infection clusters in a large German city based on integrated genomic surveillance, outbreak analysis, and contact tracing. Epidemiology 2021 (preprint). https://doi.org/10.1101/2021.02.13.21251678
Einhauser S, Peterhoff D, Niller HH, et al. Spectrum bias and individual strengths of SARS-CoV-2 serological tests—A population-based evaluation. Diagnostics 2021; 11(10). https://doi.org/10.3390/diagnostics11101843
Lapuente D, Fuchs J, Willar J, et al. Protective mucosal immunity against SARS-CoV-2 after heterologous systemic prime-mucosal boost immunization. Nat Commun 2021; 12(1). https://doi.org/10.1038/s41467-021-27063-4
Weigang S, Fuchs J, Zimmer G, et al. Within-host evolution of SARS-CoV-2 in an immunosuppressed COVID-19 patient as a source of immune escape variants. Nat Commun 2021; 12(1). https://doi.org/10.1038/s41467-021-26602-3
Muenchhoff M, Graf A, Krebs S. et al. Genomic epidemiology reveals multiple introductions of SARS-CoV-2 followed by community and nosocomial spread, Germany, February to May 2020. Eurosurveillance 2021; 26(45). https://doi.org/10.2807/1560-7917.ES.2021.26.43.2002066
Dächert C, Muenchhoff M, Graf A, et al. Rapid and sensitive identification of omicron by variant-specific PCR and nanopore sequencing: paradigm for diagnostics of emerging SARS-CoV-2 variants. Med Microbiol Immunol 2022; 211(1). https://doi.org/10.1007/s00430-022-00728-7
Wagner R, Peterhoff D, Beileke S, et al. Estimates and determinants of SARS-Cov-2 seroprevalence and infection fatality ratio using latent class analysis: The population-based Tirschenreuth study in the hardest-hit German county in spring 2020. Viruses 2021; 13(6). https://doi.org/10.3390/v13061118
Barros-Martins J, Hammerschmidt SI, Cossmann A. Humoral and cellular immune response against SARS-CoV-2 variants following heterologous and homologous ChAdOx1 nCoV-19/BNT162b2 vaccination. MedRxiv 2021 (preprint). https://doi.org/10.1101/2021.06.01.21258172
Bošnjak B, Odak I, Barros-Martins J, et al. Intranasal delivery of MVA vector vaccine induces effective pulmonary immunity against SARS-CoV-2 in rodents. Front Immunol 2021; 12. https://doi.org/10.3389/fimmu.2021.772240
Chen H, Maul‐Pavicic A, Holzer M, et al. Detection and functional resolution of soluble immune complexes by an FcγR reporter cell panel. EMBO Mol Med 2022; 14(1). https://doi.org/10.15252/emmm.202114182
Halwe S, Kupke A, Vanshylla K, et al. Intranasal administration of a monoclonal neutralizing antibody protects mice against SARS-CoV-2 infection. Viruses 2021; 13(8). https://doi.org/10.3390/v13081498
Klüpfel J, Koros RC, Dehne K, et al. Automated, flow-based chemiluminescence microarray immunoassay for the rapid multiplex detection of IgG antibodies to SARS-CoV-2 in human serum and plasma (CoVRapid CL-MIA). Anal Bioanal Chem 2021; 413(22). https://doi.org/10.1007/s00216-021-03315-6
Ankerhold J, Giese S, Kolb P, et al. Circulating multimeric immune complexes drive immunopathology in COVID-19. Immunology 2021 (preprint). https://doi.org/10.1101/2021.06.25.449893
Hammerschmidt SI, Bosnjak B, Bernhardt G, et al. Neutralization of the SARS-CoV-2 Delta variant after heterologous and homologous BNT162b2 or ChAdOx1 nCoV-19 vaccination. Cell Mol Immunol 2021; 18(10). https://doi.org/10.1038/s41423-021-00755-z
Hammerschmidt SI, Thurm C, Bošnjak B, et al. Robust induction of neutralizing antibodies against the SARS‐CoV‐2 Delta variant after homologous Spikevax or heterologous Vaxzevria‐Spikevax vaccination. Eur J Immunol 2022; 52(2). https://doi.org/10.1002/eji.202149645
Koerber N, Priller A, Yazici S, et al. Dynamics of spike-and nucleocapsid specific immunity during long-term follow-up and vaccination of SARS-CoV-2 convalescents. Nat Commun 2022; 13(1). https://doi.org/10.1038/s41467-021-27649-y
Wratil PR, Stern M, Priller A, et al. Three exposures to the spike protein of SARS-CoV-2 by either infection or vaccination elicit superior neutralizing immunity to all variants of concern. Nat Med 2022; 28. https://doi.org/10.1038/s41591-022-01715-4
Weinberger T, Steffen J, Osterman A, et al. Prospective longitudinal serosurvey of healthcare workers in the first wave of the Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) pandemic in a quaternary care hospital in Munich, Germany. Clin Infect Dis 2021; 73(9). https://doi.org/10.1093/cid/ciaa1935
Tenbusch M, Schumacher S, Vogel E, et al. Heterologous prime–boost vaccination with ChAdOx1 nCoV-19 and BNT162b2, Lancet Infect Dis 2021; 21(9). https://doi.org/10.1016/S1473-3099(21)00420-5

Surveillance Management und Tools

Köster A, Bludau A, Devcic S, et al. Infection surveillance measures during the COVID-19 pandemic in Germany. GMS Hyg Infect Control 2021; 16. https://doi.org/10.3205/dgkh000398
Alm E, Broberg EK, Connor T, et al. Geographical and temporal distribution of SARS-CoV-2 clades in the WHO European Region, January to June 2020. Eurosurveillance 2020; 25(32). https://doi.org/10.2807/1560-7917.ES.2020.25.32.2001410
Erber J, Kappler V, Haller B, et al. Strategies for infection control and prevalence of anti-SARS-CoV-2 IgG in 4,554 employees of a university hospital in Munich, Germany. MedRxiv 2020 (preprint). https://doi.org/10.1101/2020.10.04.20206136
Knolle P, Körber N, Priller A, et al. Long-term follow-up of SARS-CoV-2 convalescents reveals distinct magnitude of spike-specific immunity after viral re-exposure and vaccination. Research square 2021 (preprint). https://doi.org/10.21203/rs.3.rs-677167/v1
Wulff A, Biermann P, von Landesberger T, et al. Tracing COVID-19 infection chains within healthcare institutions: Another brick in the wall against SARS-CoV-2. MedInfo Conference 2021. https://imia-medinfo.org/medinfo21/
Wulff A, Baier C, Marschollek M, et al. SmICS: Eine smarte Lösung zur automatisierten Ausbruchserkennung im Krankenhaus. Gesundhyte 2021; 14. https://www.systembiologie.de/lw_resource/datapool/systemfiles/elements/files/D344CA9772B73013E0537E695E8653F9/live/document/PTJ-009_gesundhyte_14_2021_dt_WEB-ISSN_2702-2552_211215_WEB.pdf
Wulff A, Biermann P, von Landesberger T, et al. A Smart Infection Control System for COVID-19 Infections in Hospitals. Conference on 66. Jahrestagung der Deutschen Gesellschaft für Medizinische Informatik, Biometrie und Epidemiologie e.V. (GMDS) 2021. GMS 2021. https://www.egms.de/static/de/meetings/gmds2021/21gmds058.shtml
Heinemann S, Bludau A, Kaba H, et al. SARS-CoV-2 surveillance and testing: results of a survey from the Network of University Hospitals (NUM), B-FAST. GMS Hyg Infect Control 2021; 16. https://doi.org/10.3205/dgkh000402
Kuhlmann E, Heinemann S, Bludau A, et al. Managing protection and surveillance of health workers during COVID-19: German multi-centre survey (abstract). Eur J Public Health 2021; 31 (Supplement 3). https://doi.org/10.1093/eurpub/ckab165.441
Heinemann S, Bludau A, Kaba H, et al. COVID-19 surveillance and testing strategies für patiens in German hospitals – results from a cross-sectional study (abstract). DGHM 2021. https://www.egms.de/static/de/journals/dgkh/2021-16/dgkh000402.shtml, manuscript submitted
Bludau A, Anton M, Heinemann S, et al. COVID-19 vaccination and immunization surveillance for employees in German hospitals – results from a cross-sectional study (abstract). DGHM 2021, https://www.dghm-kongress.de/fileadmin/congress/media/dghm2021/pdf/DGHM_2021_digital_Programme_booklet.pdf, manuscript submitted

Bevölkerung

Deckert A, Anders S, de Allegri M, et al. Effectiveness and cost-effectiveness of four different strategies for SARS-CoV-2 surveillance in the general population (CoV-Surv Study): a structured summary of a study protocol for a cluster-randomised, two-factorial controlled trial. Trials 2021; 22(1). https://doi.org/10.1186/s13063-020-04982-z
Deckert A, Anders S, De Allegri M, et al. Effectiveness and cost-effectiveness of four different strategies for SARS-CoV-2 surveillance in the general population (CoV-Surv Study): study protocol for a two-factorial randomized controlled multi-arm trial with cluster sampling. Trials 2021; 22(1). https://doi.org/10.1186/s13063-021-05619-5
Föh B, Borsche M, Balck A, et al. Complications of nasal and pharyngeal swabs – a relevant challenge of the COVID-19 pandemic? Eur Respir J 2021; 57)(. https://doi.org/10.1183/13993003.04004-2020
Klein C, Borsche M, Balck A, et al. One-year surveillance of SARS-CoV-2 transmission of the ELISA Cohort: A model for population-based monitoring of infection risk. Science Adv (in press)
Oberste M, Pusch LM, Roth R, et al. Protocol of the Cologne Corona Surveillance (CoCoS) study: A prospective population-based cohort study. BMC Public Health 2021; 21(1). https://doi.org/10.1186/s12889-021-11206-9

Schulen und KiTas

Döpfner M, Adam J, Habbel C, et al. Die psychische Belastung von Kindern und Jugendlichen und ihren Familien während der COVID-19-Pandemie und der Zusammenhang mit emotionalen und Verhaltensauffälligkeiten. Bundesgesundheitsbl 2021; 64. https://doi.org/10.1007/s00103-021-03455-1
Joachim A, Dewald F, Suárez I, et al. Pooled RT-qPCR testing for SARS-CoV-2 surveillance in schools: A cluster randomised trial. EClinicalMedicine 2021; 39. https://doi.org/10.1016/j.eclinm.2021.101082

Anwendungen – Risikobereiche

Stemler J, Kramer T, Dimitriou V et al. Mobile PCR-based surveillance for SARS-CoV-2 to reduce visiting restrictions in nursing homes during the COVID-19 pandemic: a pilot study. Infection 2021. https://doi.org/10.1007/s15010-021-01716-4
Gross O, Moerer O, Rauen T, et al. Validation of a Prospective Urinalysis-Based Prediction Model for ICU Resources and Outcome of COVID-19 Disease: A Multicenter Cohort Study. J Clin Med 2021; 10(14). https://doi.org/10.3390/jcm10143049
Alvarez-Fischer D, Borsche M, Alexander Balck, et al. Spreading of SARS-CoV-2 Among Adult Asylum Seekers in Refugee Shelters in Germany. Lancet, 2021 (preprint). https://doi.org/10.2139/ssrn.3889435
Torres Reyes CR, Steinmann E, Timmesfeld N, et al. Students in Dormitories were not major drivers of the pandemic during winter term 2020/2021: A cohort study with RT-PCR and antibody surveillance in a German university city. COVID 2021; 1(1). https://doi.org/10.3390/covid1010029
Mürbe D, Kriegel M, Lange J, et al. Aerosol emission of adolescents voices during speaking, singing and shouting. PLoS ONE 2021; 16(2). https://doi.org/10.1371/journal.pone.0246819
Mürbe, D., Kriegel, M., Lange, J. et al. Aerosol emission in professional singing of classical music. Sci Rep2021; 11. https://doi.org/10.1038/s41598-021-93281-x
SARS-CoV-2 antibody status in participants of church events of the Protestant Church of Kurhessen-Waldeck: https://www.degruyter.com/journal/key/labm/html
Gorji H, Stauffer N, Lunati I, et al. Projection of healthcare demand in Germany and Switzerland urged by omicron wave (January-March 2022). MedRxiv 2022 (preprint). https://doi.org/10.1101/2022.01.24.22269676
Weber M, Plew M, Neumann Weber C, et al. Perceived importance of pandemic interventions for attending cultural events – Findings from Germany. BMC Public Health 2021 (currently under review). https://doi.org/10.21203/rs.3.rs-776085/v1
Veröffentlichung Dashboard GCS https://www.unimedizin-mainz.de/GCS/dashboard/#/app/pages/AktuelleErgebnisse/ergebnisse
Nordsiek F, Bodenschatz E, Bagheri G, et al. Risk assessment for airborne disease transmission by poly-pathogen aerosols. PLOS One 2021. https://doi.org/10.1371/journal.pone.0248004
Bagheri G, Thiede B, Hejazi B, et al. An upper bound on one-to-one exposure to infectious human respiratory particles. PNAS 2021; 118(49). https://doi.org/10.1073/pnas.2110117118

Kliniken

Möckel M, Corman VM, Stegemannd MS, et al. SARS-CoV-2 antigen rapid immunoassay for diagnosis of COVID-19 in the emergency departmentnt. Biomarker 2021; 26(3). https://doi.org/10.1080/1354750X.2021.1876769
Toptana T, Eckermanna L, Pfeiffer AE, et al. Evaluation of a SARS-CoV-2 rapid antigen test: Potential to help reduce community spread? J Clin Virol 2021; 135. https://doi.org/10.1016/j.jcv.2020.104713
Korenkov M, Poopalasingam N, Madler M, et al. Evaluation of a Rapid Antigen Test To Detect SARS-CoV-2 Infection and Identify Potentially Infectious Individuals. J Clin Microbiol 2021; 59(9). https://doi.org/10.1128/JCM.00896-21
Kahn M, Schuierer L, Bartenschlager C, et al. Performance of antigen testing for diagnosis of COVID-19: a direct comparison of a lateral flow device to nucleic acid amplification based tests. BMC Infect Dis 2021; 21 (1). https://doi.org/10.1186/s12879-021-06524-7
Wunsch M, Aschemeier D, Hegera E, et al. Safe and effective pool testing for SARS-CoV-2 detection. J Clin Virol 2021; 145. https://doi.org/10.1016/j.jcv.2021.105018
Schneider S, Piening B, Nouri-Pasovsky PA, et al. SARS-Coronavirus-2 cases in healthcare workers may not regularly originate from patient care: lessons from a university hospital on the underestimated risk of healthcare worker to healthcare worker transmission. Antimicrob Resist Infect Control 2020; 9(1). https://doi.org/10.1186/s13756-020-00848-w
Wratil PR, Schmacke NA, Osterman A, et al. In-depth profiling of COVID-19 risk factors and preventive measures in healthcare workers. Infection 2022; 50. https://doi.org/10.1007/s15010-021-01672-z
Würstle S, Spinner CD, Voit F, et al. Self-sampling versus health care professional-guided swab collection for SARS-CoV-2 testing. Infection 2021; 49(5). https://doi.org/10.1007/s15010-021-01614-9
Mayer M, Zellmer S, Zenk J, et al. Status quo after one year of COVID-19 pandemic in otolaryngological hospital-based departments and private practices in Germany. Eur Arch Otorhinolaryngol 2022; 279(2). https://doi.org/10.1007/s00405-021-06992-2
Zellmer S, Bachmann E, Muzalyova A, et al. One year of the COVID-19 pandemic in dental medical facilities in Germany: A questionnaire-based analysis. Int J Environ Res Public Health 2022; 19(1). https://doi.org/10.3390/ijerph19010175
Kahn M, Zellmer S, Ebigbo A, et al. Ein Jahr Covid-19: Testung, Verwendung von Schutzausrüstung und Auswirkungen auf die Gastrointestinale Endoskopie in Deutschland. Z Gastroenterol 2021; 59(12). https://doi.org/10.1055/a-1649-8184
Zellmer S, Kahn M, Ebigbo A, et al. Ein Jahr Covid-19: Testung, Verwendung von Schutzausrüstung und Auswirkungen auf die Gastrointestinale Endoskopie in Deutschland. Z Gastroenterol 2021; 59(8). https://doi.org/10.1055/s-0041-1734140
Augustin M, Schommers P, Suárez I, et al. Rapid response infrastructure for pandemic preparedness in a tertiary care hospital: lessons learned from the COVID-19 outbreak in Cologne, Germany, February to March 2020. Euro Surveill 2020; 25(21). https://doi.org/10.2807/1560-7917.ES.2020.25.21.2000531
Ebigbo A, Römmele C, Bartenschlager C, et al. Cost-effectiveness analysis of SARS-CoV-2 infection prevention strategies including pre-endoscopic virus testing and use of high risk personal protective equipment. Endoscopy 2021; 53(2). https://doi.org/10.1055/a-1294-0427
Bartenschlager C, Frey R, Freitag M, et al. Managing hospital visitor admission during Covid-19: A discrete-event simulation by the data of a German University Hospital. Gehalten auf der Hawaii International Conference on System Sciences 2022. https://doi.org/10.24251/HICSS.2022.449
Bartenschlager C, Römmele C, Temizel S. Befragung zum Besuchsmanagement: Wie Pflegeeinrichtungen Besuche während der COVID-19-Pandemie organisierten. Protzenziale digitaler Systeme kaum genutzt. CAREkonkret 2021; 32/33. https://opus.bibliothek.uni-augsburg.de/opus4/88555
Jukic M, Dunkel A, Haller B, et al. Persistent loss of smell and taste perception in subjects with anti-SARS-CoV-2 antibodies.
Demleitner AF, Wolff A, Erber J, et al. Practice approaches to outpatient management of people living with Parkinson’s disease during the COVID-19 pandemic.
Wolff AW, Haller B, Demleitner AF, et al. Impact of the COVID-19 pandemic on patients with Parkinson’s disease from the perspective of treating physicians – a nationwide cross-sectional study.
Kahn M, Zellmer S, Ebigbo A, et al. Progress of the vaccination campaign among HCW in AGP in Germany.

Molekulargenetische Surveillance Plattform

Walker A, Houwaart T, Finzer P, et al. Characterization of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) infection clusters based on integrated genomic surveillance, outbreak analysis and contact tracing in an urban setting. Clin Infect Dis 2021; 74(6). https://doi.org/10.1093/cid/ciab588
Walker A, Houwaa T, Wienemann T, et al. Genetic structure of SARS-CoV-2 reflects clonal superspreading and multiple independent introduction events, North-Rhine Westphalia, Germany, February and March 2020. Euro Surveillance 2020; 25(22). https://doi.org/10.2807/1560-7917.ES.2020.25.22.2000746
Jensen B, Luebke N, Feldt T, et al. Emergence of the E484K mutation in SARS-COV-2-infected immunocompromised patients treated with bamlanivimab in Germany. Lancet Reg Health Eur 2021; 8. https://doi.org/10.1016/j.lanepe.2021.100164
Tober-Lau P, Schwarz T, Hillus D, et al. Outbreak of SARS-CoV-2 B.1.1.7 Lineage after Vaccination in Long-Term Care Facility, Germany, February-March 2021. Emerg Infect Dis 2021; 27(8). https://doi.org/10.3201/eid2708.210887
Niemeyer D, Schroeder S, Friedmann K. Post-entry, spike-dependent replication advantage of B.1.1.7 and B.1.617.2 over B.1 SARS-CoV-2 in an ACE2-deficient human lung cell line. BioRxiv 2021 (preprint). https://doi.org/10.1101/2021.10.20.465121
Houwaart T, Belhaj S, Tawalbeh E, et al. Integrated Genomic Surveillance reveals extensive onward transmission of travel-imported SARS-CoV-2 infections in the community. MedRxiv 2021 (preprint). https://doi.org/10.1101/2021.10.18.21264530
Muenchhoff M, Graf A, Krebs S, et al. Genomic epidemiology reveals multiple introductions of SARS-CoV-2 followed by community and nosocomial spread, Germany, February to May 2020. Euro Surveill 2021; 26(43). https://doi.org/10.2807/1560-7917.ES.2021.26.43.2002066
Rubio-Acero R, Beyerl J, Muenchhoff M, et al. Spatially resolved qualified sewage spot sampling to track SARS-CoV-2 dynamics in Munich: One year of experience. Sci Total Environ 2021; 797. https://doi.org/10.1016/j.scitotenv.2021.149031
Osterman A, Iglhaut M, Lehner A, et al. Comparison of four commercial, automated antigen tests to detect SARS-CoV-2 variants of concern. Med Microbiol Immunol 2021; 210. https://doi.org/10.1007/s00430-021-00719-0
Gaitzsch E, Passerini V, Khatamzas E, et al. COVID-19 in Patients Receiving CD20-depleting Immunochemotherapy for B-cell Lymphoma. Hemasphere 2021; 5(7). https://doi.org/10.1097/HS9.000000000000060

CEOsys

Andreas M, Piechotta V, Skoetz N, Grummich K, Becker M, Joos L, Becker G, Meissner W, Boehlke C. Interventions for palliative symptom control in COVID‐19 patients. Cochrane Database of Systematic Reviews 2021, Issue 8. Art. No.: CD015061. DOI: 10.1002/14651858.CD015061.
Ansems K, Grundeis F, Dahms K, Mikolajewska A, Thieme V, Piechotta V, Metzendorf M-I, Stegemann M, Benstoem C, Fichtner F. Remdesivir for the treatment of COVID‐19. Cochrane Database of Systematic Reviews 2021, Issue 8. Art. No.: CD014962. DOI: 10.1002/14651858.CD014962.
Burns J, Movsisyan A, Stratil JM, Biallis RL, Coenen M, Emmert-Fees KMF, Geffert K, Hoffmann S, Horstick O, Laxy M, Klinger C, Kratzer S, Litwin T, Norris S, Pfadenhauer LM, Philipsborn P, Sell K, Stadelmaier, Verboom B, Voss S, Wabnitz K, Rehfuess EA. International travel‐related control measures to contain the COVID‐19 pandemic: a rapid review. Cochrane Database of Systematic Reviews. 2021; 3. DOI: 10.1002/14651858.CD013717.pub2.
Burns J, Movsisyan A, Rehfuess EA, Stratil JM. Border control and SARS-CoV-2: an opportunity for generating highly policy-relevant, real-world evidence, Journal of Travel Medicine. 2021; 1-3. DOI: 10.1093/jtm/taab037
Dickel S, Grimm C, Popp M, Struwe C, Sachkova A, Golinski M, Seeber C, Fichtner F, Heise D, Kranke P, Meissner W, Laudi S, Voigt-Radloff S, Meerpohl JJ, Jabs J, Mutters NT, Moerer O; German CEOsys Study Group. Infection control, prophylactic antibiotics, and testing for SARS-CoV-2 and PPE on German intensive care units: results from a national mixed methods survey. GMS Hyg Infect Control. 2021 Jun 14;16:Doc21. doi: 10.3205/dgkh000392. PMID: 34194922; PMCID: PMC8204667.
Dickel S, Grimm C, Popp M, Struwe C, Sachkova A, Golinski M, Seeber C, Fichtner F, Heise D, Kranke P, Meissner W, Laudi S, Voigt-Radloff S, Meerpohl J, Moerer O, On Behalf Of The German CEOsys Study Group. A Nationwide Cross-Sectional Online Survey on the Treatment of COVID-19-ARDS: High Variance in Standard of Care in German ICUs. J Clin Med. 2021 Jul 29;10(15):3363. doi: 10.3390/jcm10153363. PMID: 34362146; PMCID: PMC8347152.
Grimm C, Dickel S, Sachkova A, Popp M, Golinksi M, Fichtner F, Kranke P, Seeber C, Laudi S, Voigt-Radloff S, Moerer O. Targeted Minimal Staff-to-Patient Ratios Are Unachievable - A Nationwide Survey in German ICUs During the COVID-19 Pandemic. Cureus. 2021 Jun 19;13(6):e15755. doi: 10.7759/cureus.15755. PMID: 34290932; PMCID: PMC8289403.
Hildebrandt J, Metzendorf MI, Jakob T. Evaluierung der deutschen Datenbank Current Contents Medizin (CC MED) als potenzielle Datenquelle für das Cochrane COVID-19-Studienregister. GMS Med Inform Biom Epidemiol. 2021;17(3):Doc12. DOI: 10.3205/mibe000226, URN: urn:nbn:de:0183-mibe0002267
Holzmann-Littig C, Braunisch MC, Kranke P, Popp M, Seeber C, Fichtner F, Littig B, Carbajo-Lozoya J, Allwang C, Frank T, Meerpohl JJ, Haller B, Schmaderer C. COVID-19 Vaccination Acceptance and Hesitancy among Healthcare Workers in Germany. Vaccines (Basel). 2021 Jul 12;9(7):777. doi: 10.3390/vaccines9070777. PMID: 34358193; PMCID: PMC8310090.
Iannizzi C, Akl EA, Kahale LA et al. Methods and guidance on conducting, reporting, publishing and appraising living systematic reviews: a scoping review protocol [version 1; peer review: 1 approved]. F1000Research 2021, 10:802 (https://doi.org/10.12688/f1000research.55108.1)
Iannizzi C, Dorando E, Burns J, Weibel S, Dooley C, Wakeford H, Estcourt LJ, Skoetz N, Piechotta V, Methodological challenges for living systematic reviews conducted during the COVID-19 pandemic: a concept paper, Journal of Clinical Epidemiology (2021), doi: doi.org/10.1016/j.jclinepi.2021.09.013 Epub ahead of print.
Klinger C, Burns J, Movsisyan A, Biallas R, Norris SL, Rabe JE, Stratil JM, Voss S, Wabnitz K, Rehfuess EA, Verboom B. Unintended health and societal consequences of international travel measures during the COVID-19 pandemic: A scoping review. J Travel Med. 2021 Aug 9:taab123. doi: 10.1093/jtm/taab123. Epub ahead of print. PMID: 34369562.
Kluge S, Malin JJ, Fichtner F, Müller OJ, Skoetz N, Karagiannidis C; Guideline Development Group. Recommendations on the In-Hospital Treatment of Patients With COVID-19. Dtsch Arztebl Int. 2021 Dec 27;(Forthcoming):arztebl.m2021.0374. doi: 10.3238/arztebl.m2021.0374. Epub ahead of print. PMID: 34789365.
Kreuzberger N, Hirsch C, Chai KL, Tomlinson E, Khosravi Z, Popp M, Neidhardt M, Piechotta V, Salomon S, Valk SJ, Monsef I, Schmaderer C, Wood EM, So-Osman C, Roberts DJ, McQuilten Z, Estcourt LJ, Skoetz N. SARS-CoV-2-neutralising monoclonal antibodies for treatment of COVID-19. Cochrane Database Syst Rev. 2021 Sep 2;9(9):CD013825. doi: 10.1002/14651858.CD013825.pub2. PMID: 34473343; PMCID: PMC8411904.
Krishnaratne S, Littlecott H, Sell K, Burns J, Rabe JE, Stratil JM, Litwin T, Kreutz C, Coenen M, Geffert K, Boger AH, Movsisyan A, Kratzer S, Klinger C, Wabnitz K, Strahwald B, Verboom B, Rehfuess E, Biallas RL, Jung-Sievers C, Voss S, Pfadenhauer LM. Measures implemented in the school setting to contain the COVID‐19 pandemic: a rapid review. Cochrane Database of Systematic Reviews 2022, Issue 1. Art. No.: CD015029. DOI: 10.1002/14651858.CD015029
Krishnaratne S, Pfadenhauer LM, Coenen M, Geffert K, Jung-Sievers C, Klinger C, Kratzer S, Littlecott H, Movsisyan A, Rabe JE, Rehfuess E, Sell K, Strahwald B, Stratil JM, Voss S, Wabnitz K, Burns J. Measures implemented in the school setting to contain the COVID-19 pandemic: a scoping review. Cochrane Database Syst Rev. 2020 Dec 17;12:CD013812. doi: 10.1002/14651858.CD013812. PMID: 33331665.
Kunzler AM, Röthke N, Günthner L, Stoffers-Winterling J, Tüscher O, Coenen M, Rehfuess E, Schwarzer G, Binder H, Schmucker C, Meerpohl JJ, Lieb K. Mental burden and its risk and protective factors during the early phase of the SARS-CoV-2 pandemic: systematic review and meta-analyses. Global Health. 2021 Mar 29;17(1):34. doi: 10.1186/s12992-021-00670-y.
Kunzler, A. M., Stoffers-Winterling, J., Stoll, M., Mancini, A. L., Lehmann, S., Blessin, M., Gilan, D., Helmreich, I., Hufert, F., & Lieb, K. (2021). Mental health and psychosocial support strategies in highly contagious emerging disease outbreaks of substantial public concern: A systematic scoping review. PloS one, 16(2), e0244748. doi.org/10.1371/journal.pone.0244748
Malin JJ, Spinner CD, Janssens U, Welte T, Weber-Carstens S, Schälte G, Gastmeier P, Langer F, Wepler M, Westhoff M, Pfeifer M, Rabe KF, Hoffmann F, Böttiger BW, Weinmann-Menke J, Kersten A, Berlit P, Krawczyk M, Nehls W, Fichtner F, Laudi S, Stegemann M, Skoetz N, Nothacker M, Marx G, Karagiannidis C, Kluge S. Key summary of German national treatment guidance for hospitalized COVID-19 patients Key pharmacologic recommendations from a national German living guideline using an Evidence to Decision Framework (last updated 17.05.2021). Infection. 2021 Jul 6. doi: 10.1007/s15010-021-01645-2. Epub ahead of print. PMID: 34228347.
Meerpohl JJ, Voigt-Radloff S, Rueschemeyer G, Balzer F, Benstoem C, Binder H, Boeker M, Burns J, Dirnagl U, Featherstone R, Fichtner F, Grundmann H, Hengel H, Kempf V, Kern W, Kranke P, Laudi S, Lieb S, MaunA, Mavergames C, Metzendorf MI, Nothacker M, Schmaderer C, Schmucker C, Schwingshackl L, Skoetz N, Steckelberg A, Stegemann M, Strech D, Moerer O, Rehfuess E, Spies C, on behalf of the CEOsys consortium. CEOsys: Creating an ecosystem for COVID-19 evidence In: Collaborating in response to COVID-19: editorial and methods initiatives across Cochrane. Cochrane Database of Systematic Reviews 2020;(12 Suppl 1) https://doi.org/10.1002/14651858.CD202002
Metzendorf MI. Das Cochrane COVID-19 Studienregister – eine studienbasierte, strukturierte Datenbank zur effizienten Identifizierung wissenschaftlicher Evidenz. GMS Med Bibl Inf. 2021 September; 21(1-2):Doc09. doi: 10.3205/mbi000498.
Metzendorf MI, Featherstone RM. Evaluation of the comprehensiveness, accuracy and currency of the Cochrane COVID-19 Study Register for supporting rapid evidence synthesis production. Res Synth Methods. 2021 Jun 5. doi: 10.1002/jrsm.1501. Online ahead of print.
Metzendorf MI, Hildebrandt J, Jakob T, Featherstone RM. Das Cochrane COVID-19 Studienregister – eine studienbasierte, strukturierte Datenbank zur effizienten Identifizierung wissenschaftlicher Evidenz. Vortrag. 22. Jahrestagung des Deutschen Netzwerks Evidenzbasierte Medizin.
Mikolajewska A, Fischer A-L, Piechotta V, Mueller A, Metzendorf M-I, Becker M, Dorando E, Pacheco RL, Martimbianco ALC, Riera R, Skoetz N, Stegemann M. Colchicine for the treatment of COVID‐19. Cochrane Database of Systematic Reviews 2021, Issue 10. Art. No.: CD015045. DOI: 10.1002/14651858.CD015045.
Piechotta V, Iannizzi C, Chai KL, Valk SJ, Kimber C, Dorando E, Monsef I, Wood EM, Lamikanra AA, Roberts DJ, McQuilten Z, So-Osman C, Estcourt LJ, Skoetz N. Convalescent plasma or hyperimmune immunoglobulin for people with COVID‐19: a living systematic review. Cochrane Database of Systematic Reviews 2021, Issue 5. Art. No.: CD013600. DOI: 10.1002/14651858.CD013600.pub4.
Popp M, Kranke P, Meybohm P, Metzendorf MI, Skoetz N, Stegemann MS, Weibel S. Evidence on the efficacy of ivermectin for COVID-19: another story of apples and oranges. BMJ Evid Based Med. 2021 Aug 20:bmjebm-2021-111791. doi: 10.1136/bmjebm-2021-111791. Epub ahead of print. PMID: 34417268
Popp M, Stegemann M, Metzendorf M-I, Gould S, Kranke P, Meybohm P, Skoetz N, Weibel S. Ivermectin for preventing and treating COVID‐19. Cochrane Database of Systematic Reviews 2021, Issue 7. Art. No.: CD015017. DOI: 10.1002/14651858.CD015017.pub2.
Popp M, Stegemann M, Riemer M, Metzendorf M-I, Romero CS, Mikolajewska A, Kranke P, Meybohm P, Skoetz N, Weibel S. Antibiotics for the treatment of COVID‐19. Cochrane Database of Systematic Reviews 2021, Issue 10. Art. No.: CD015025. DOI: 10.1002/14651858.CD015025
Reis S, Popp M, Schmid B, Stegemann M, Metzendorf MI, Kranke P, Meybohm P, Weibel S. Safety and Efficacy of Intermediate- and Therapeutic-Dose Anticoagulation for Hospitalised Patients with COVID-19: A Systematic Review and Meta-Analysis. J Clin Med. 2021 Dec 23;11(1):57. doi: 10.3390/jcm11010057. PMID: 35011804; PMCID: PMC8745419.
Salholz-Hillel M, Grabitz P, Pugh-Jones M, Strech D, DeVito NJ. Results availability and timeliness of registered COVID-19 clinical trials: interim cross-sectional results from the DIRECCT study. BMJ Open. 2021 Nov 22;11(11):e053096. doi: 10.1136/bmjopen-2021-053096. PMID: 34810189; PMCID: PMC8609493.
Schmid B, Griesel M, Fischer AL, Romero CS, Metzendorf MI, Weibel S, Fichtner F. Awake Prone Positioning, High-Flow Nasal Oxygen and Non-Invasive Ventilation as Non-Invasive Respiratory Strategies in COVID-19 Acute Respiratory Failure: A Systematic Review and Meta-Analysis. J Clin Med. 2022 Jan 13;11(2):391. doi: 10.3390/jcm11020391. PMID: 35054084.
Seeber, C., Popp, M., Meerpohl, J.J. et al. COVID-19-Pandemie: Präferenzen und Barrieren für die Disseminierung von Evidenzsynthesen. Anaesthesist (2021). doi.org/10.1007/s00101-021-01037-z
Stratil JM, Biallas RL, Burns J, Arnold L, Geffert K, Kunzler AM, Monsef I, Stadelmaier J, Wabnitz K, Litwin T, Kreutz C, Boger AH, Lindner S, Verboom B, Voss S, Movsisyan A. Non‐pharmacological measures implemented in the setting of long‐term care facilities to prevent SARS‐CoV‐2 infections and their consequences: a rapid review. Cochrane Database of Systematic Reviews 2021, Issue 9. Art. No.: CD015085. DOI: 10.1002/14651858.CD015085.pub2.
Stroehlein JK, Wallqvist J, Iannizzi C, Mikolajewska A, Metzendorf MI, Benstoem C, Meybohm P, Becker M, Skoetz N, Stegemann M, Piechotta V. Vitamin D supplementation for the treatment of COVID-19: a living systematic review. Cochrane Database Syst Rev. 2021 May 24;5(5):CD015043. doi: 10.1002/14651858.CD015043. PMID: 34029377; PMCID: PMC8406457.
Struwe, Claudia; Golinski, Martin; Grimm, Clemens; Dickel, Steffen; Grummich, Kathrin; Nothacker, Monika; Voigt-Radloff, Sebastian; Meerpohl, Jörg; Moerer, Onnen; Dtsch Arztebl Int 2022; 119: 23-30; DOI: 10.3238/arztebl.m2022.0006; ONLINE first
Wagner C, Griesel M, Mikolajewska A, Mueller A, Nothacker M, Kley K, Metzendorf MI, Fischer AL, Kopp M, Stegemann M, Skoetz N, Fichtner F. Systemic corticosteroids for the treatment of COVID-19. Cochrane Database Syst Rev. 2021 Aug 16;8(8):CD014963. doi: 10.1002/14651858.CD014963. PMID: 34396514; PMCID: PMC8406706.

CODEX

Sedlmayr B, Sedlmayr M, Schüttler C, et al. Improving collaborative COVID-19 research of University Hospitals in Germany: Formative usability evaluation of the CODEX-Feasibility Portal. Appl Clin Inform 2022;13:400–409. DOI: 10.1055/s-0042-1744549
Medenwald D, Brunner T, Christiansen H, et al. Shift of radiotherapy use during the first wave of the COVID-19 pandemic? An analysis of German inpatient data. Strahlenther Onkol. 2022;198(4):334-345. DOI: 10.1007/s00066-021-01883-1
Rosenau L, Majeed RW, Ingenerf J, et al. Generation of a Fast Healthcare Interoperability Resources (FHIR)-based Ontology for federated Feasibility Queries in the context of COVID-19: An automated approach [published online ahead of print, 2022 Feb 13]. JMIR Med Inform. 2022;10.2196/35789. DOI: 10.2196/35789
Gruendner J, Majeed RW et al. Architecture for a feasibility query portal for distributed COVID-19 Fast Healthcare Interoperability Resources (FHIR) patient data repositories: Design and Implementation Study. JMIR Medical Informatics. 11/04/2022:36709 (forthcoming/in press) DOI: 10.2196/preprints.36709

COMPASS

Muzoora MR et al. Motivating Developers to Use Interoperable Standards for Data in Pandemic Health Apps. Stud Health Technol Inform. 2021 May 27;281:1027-1028.
Holfelder, M. et al. Medical Device Regulation Efforts for mHealth Apps during the COVID-19 Pandemic—An Experience Report of Corona Check and Corona Health. J 2021, 4, 206-222.
Beierle, F. et al. Corona Health—A Study- and Sensor-Based Mobile App Platform Exploring Aspects of the COVID-19 Pandemic. Int. J. Environ. Res. Public Health 2021, 18, 7395.
F. Beierle et al. "Public Perception of the German COVID-19 Contact-Tracing App Corona-Warn-App," 2021 IEEE 34th International Symposium on Computer-Based Medical Systems, 2021, pp. 342-347.
Thole D, Ole Diesterhöft T, Vogel S, Greve M, Bauer E, Strathmann S, Elsner C, Kolbe L, Krefting D. Relevant Aspects for Sustainable Open Source Pandemic Apps and Platform Deployment with Focus on Community Building. Stud Health Technol Inform. 2021 Sep 21;283:186-193.
Buhr, L., Nordmeyer, E., & Schicktanz, S. (2021). Pandemie-Apps: Breite Akzeptanz. Dtsch Arztebl International, 118(27–28), A-1362 / B-1128.
Muzoora MR et al. 66. Jahrestagung der Deutschen Gesellschaft für Medizinische Informatik, Biometrie und Epidemiologie e. V.(GMDS), 12. Jahreskongress der Technologie-und Methodenplattform für die vernetzte medizinische Forschung e. V.(TMF).
Muzoora MR et al. Towards FAIR Patient Reported Outcome: Application of the Interoperability Principle for Mobile Pandemic Apps. Stud Health Technol Inform. 2021 Nov 18;287:85-86.
M. Winter et al. "Exploring the Usability of the German COVID-19 Contact Tracing App in a Combined Eye Tracking and Retrospective Think Aloud Study," 2021 43rd Annual International Conference of the IEEE Engineering in Medicine & Biology Society, 2021, pp. 2215-2221.
Buhr L, Schicktanz S, Nordmeyer E. Attitudes Toward Mobile Apps for Pandemic Research Among Smartphone Users in Germany: National Survey. JMIR Mhealth Uhealth 2022;10(1):e31857.

COVIM

Akbil, B. et al. Early and Rapid Identification of COVID-19 Patients with Neutralizing Type I Interferon Auto-antibodies. Journal of clinical immunology; https://doi.org/10.1007/s10875-022-01252-2 (2022).
Arora, P. et al. Delta variant (B.1.617.2) sublineages do not show increased neutralization resistance. Cellular & molecular immunology 18, 2557–2559; https://doi.org/10.1038/s41423-021-00772-y (2021).
Arora, P. et al. SARS-CoV-2 variants C.1.2 and B.1.621 (Mu) partially evade neutralization by antibodies elicited upon infection or vaccination. Cell reports 39, 110754; https://doi.org/10.1016/j.celrep.2022.110754 (2022).
Arora, P. et al. No evidence for increased cell entry or antibody evasion by Delta sublineage AY.4.2. Cellular & molecular immunology; https://doi.org/10.1038/s41423-021-00811-8 (2022).
Arora, P., Pöhlmann, S. & Hoffmann, M. Mutation D614G increases SARS-CoV-2 transmission. Signal transduction and targeted therapy 6, 101; https://doi.org/10.1038/s41392-021-00502-w (2021).
Arora, P. et al. B.1.617.2 enters and fuses lung cells with increased efficiency and evades antibodies induced by infection and vaccination. Cell reports, 109825; https://doi.org/10.1016/j.celrep.2021.109825 (2021).
Augustin, M. et al. Post-COVID syndrome in non-hospitalised patients with COVID-19: a longitudinal prospective cohort study. The Lancet regional health. Europe 6, 100122; https://doi.org/10.1016/j.lanepe.2021.100122 (2021).
Bacher, P. et al. Low-Avidity CD4(+) T Cell Responses to SARS-CoV-2 in Unexposed Individuals and Humans with Severe COVID-19. Immunity 53, 1258‐1271.e5; https://doi.org/10.1016/j.immuni.2020.11.016 (2020).
Barros-Martins, J. et al. Immune responses against SARS-CoV-2 variants after heterologous and homologous ChAdOx1 nCoV-19/BNT162b2 vaccination. Nature medicine 27, 1525–1529; https://doi.org/10.1038/s41591-021-01449-9 (2021).
Bošnjak, B. et al. Intranasal Delivery of MVA Vector Vaccine Induces Effective Pulmonary Immunity Against SARS-CoV-2 in Rodents. Frontiers in immunology 12, 772240; https://doi.org/10.3389/fimmu.2021.772240 (2021).
Burnett, D. L. et al. Immunizations with diverse sarbecovirus receptor-binding domains elicit SARS-CoV-2 neutralizing antibodies against a conserved site of vulnerability. Immunity 54, 2908-2921.e6; https://doi.org/10.1016/j.immuni.2021.10.019 (2021).
Chen, H. et al. Detection and functional resolution of soluble immune complexes by an FcγR reporter cell panel. EMBO Mol Med 14, e14182; https://doi.org/10.15252/emmm.202114182 (2022).
Demichev, V. et al. A time-resolved proteomic and prognostic map of COVID-19. Cell Systems; https://doi.org/10.1016/j.cels.2021.05.005 (2021).
Demichev, V. et al. A proteomic survival predictor for COVID-19 patients in intensive care. PLOS Digital Health 1, e0000007; https://doi.org/10.1371/journal.pdig.0000007 (2022).
Dulovic, A. et al. Comparative Magnitude and Persistence of Humoral SARS-CoV-2 Vaccination Responses in the Adult Population in Germany. Frontiers in immunology 13, 828053; https://doi.org/10.3389/fimmu.2022.828053 (2022).
Eberhardt, K. A. et al. Evaluation of a New Spike (S)-Protein-Based Commercial Immunoassay for the Detection of Anti-SARS-CoV-2 IgG. Microorganisms 9; https://doi.org/10.3390/microorganisms9040733 (2021).
Ercanoglu, M. S. et al. No substantial preexisting B cell immunity against SARS-CoV-2 in healthy adults. iScience 25, 103951; https://doi.org/10.1016/j.isci.2022.103951 (2022).
Fischer, D. S. et al. Single-cell RNA sequencing reveals ex vivo signatures of SARS-CoV-2-reactive T cells through 'reverse phenotyping'. Nature communications 12, 4515; https://doi.org/10.1038/s41467-021-24730-4 (2021).
Gaitzsch, E. et al. COVID-19 in Patients Receiving CD20-depleting Immunochemotherapy for B-cell Lymphoma. HemaSphere 5, e603; https://doi.org/10.1097/HS9.0000000000000603 (2021).
Georg, P. et al. Complement activation induces excessive T cell cytotoxicity in severe COVID-19. Cell; https://doi.org/10.1016/j.cell.2021.12.040 (2021).
Gieselmann, L. et al. Effective high-throughput isolation of fully human antibodies targeting infectious pathogens. Nature protocols; https://doi.org/10.1038/s41596-021-00554-w (2021).
Gornyk, D. et al. SARS-CoV-2-Seroprävalenz in Deutschland. Eine bevölkerungsbezogene sequenzielle Studie in sieben Regionen. Dtsch Arztebl Int 118, 824–831 (2021).
Groß, R. et al. Heterologous ChAdOx1 nCoV-19 and BNT162b2 prime-boost vaccination elicits potent neutralizing antibody responses and T cell reactivity against prevalent SARS-CoV-2 variants. EBioMedicine 75, 103761; https://doi.org/10.1016/j.ebiom.2021.103761 (2021).
Gruell, H. et al. mRNA booster immunization elicits potent neutralizing serum activity against the SARS-CoV-2 Omicron variant. Nature medicine; https://doi.org/10.1038/s41591-021-01676-0 (2022).
Halwe, S. et al. Intranasal Administration of a Monoclonal Neutralizing Antibody Protects Mice against SARS-CoV-2 Infection. Viruses 13; https://doi.org/10.3390/v13081498 (2021).
Hempel, T. et al. Synergistic inhibition of SARS-CoV-2 cell entry by otamixaban and covalent protease inhibitors: pre-clinical assessment of pharmacological and molecular properties. Chem. Sci. 12, 12600–12609; https://doi.org/10.1039/D1SC01494C (2021).
Hennig, V. et al. Increased risk of chronic fatigue and hair loss following COVID-19 in individuals with hypohidrotic ectodermal dysplasia. Orphanet journal of rare diseases 16, 373; https://doi.org/10.1186/s13023-021-02011-z (2021).
Hillus, D. et al. Safety, reactogenicity, and immunogenicity of homologous and heterologous prime-boost immunisation with ChAdOx1 nCoV-19 and BNT162b2: a prospective cohort study. The Lancet Respiratory Medicine; https://doi.org/10.1016/S2213-2600(21)00357-X (2021).
Hirsch, C. et al. SARS-CoV-2-neutralising monoclonal antibodies to prevent COVID-19. Cochrane Database of Systematic Reviews; https://doi.org/10.1002/14651858.CD014945 (2021).
Hoff, N.-P. et al. Delayed skin reaction after mRNA-1273 vaccine against SARS-CoV-2: a rare clinical reaction. European journal of medical research 26, 98; https://doi.org/10.1186/s40001-021-00557-z (2021).
Hoffmann, M. et al. SARS-CoV-2 variants B.1.351 and P.1 escape from neutralizing antibodies. Cell 184, 2384‐2393.e12; https://doi.org/10.1016/j.cell.2021.03.036 (2021).
Hoffmann, M. et al. SARS-CoV-2 variant B.1.617 is resistant to bamlanivimab and evades antibodies induced by infection and vaccination. Cell reports 36, 109415; https://doi.org/10.1016/j.celrep.2021.109415 (2021).
Hoffmann, M. et al. The Omicron variant is highly resistant against antibody-mediated neutralization: Implications for control of the COVID-19 pandemic. Cell; https://doi.org/10.1016/j.cell.2021.12.032 (2021).
Hoffmann, M. et al. Evidence for an ACE2-Independent Entry Pathway That Can Protect from Neutralization by an Antibody Used for COVID-19 Therapy. mBio, e0036422; https://doi.org/10.1128/mbio.00364-22 (2022).
Hoffmann, M. et al. SARS-CoV-2 mutations acquired in mink reduce antibody-mediated neutralization. Cell reports 35, 109017; https://doi.org/10.1016/j.celrep.2021.109017 (2021).
Jones, T. C. et al. Estimating infectiousness throughout SARS-CoV-2 infection course. Science (New York, N.Y.); https://doi.org/10.1126/science.abi5273 (2021).
Kantauskaite, M. et al. Intensity of mycophenolate mofetil treatment is associated with an impaired immune response to SARS-CoV-2 vaccination in kidney transplant recipients. American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons 22, 634–639; https://doi.org/10.1111/ajt.16851 (2022).
Kreuzberger, N. et al. SARS-CoV-2-neutralising monoclonal antibodies for treatment of COVID-19. Cochrane Database of Systematic Reviews 9, CD013825; https://doi.org/10.1002/14651858.CD013825.pub2 (2021).
Kreuzberger, N. et al. Persistence of immunoglobulin G after natural infection with SARS-CoV-2. Cochrane Database of Systematic Reviews; https://doi.org/10.1002/14651858.CD014946 (2021).
Liu, Z. et al. Multi-Omics Integration Reveals Only Minor Long-Term Molecular and Functional Sequelae in Immune Cells of Individuals Recovered From COVID-19. Frontiers in immunology 13, 838132; https://doi.org/10.3389/fimmu.2022.838132 (2022).
Loyal, L. et al. Cross-reactive CD4+ T cells enhance SARS-CoV-2 immune responses upon infection and vaccination. Science (New York, N.Y.); https://doi.org/10.1126/science.abh1823 (2021).
Mahoney, M. et al. A novel class of TMPRSS2 inhibitors potently block SARS-CoV-2 and MERS-CoV viral entry and protect human epithelial lung cells. Proceedings of the National Academy of Sciences of the United States of America 118; https://doi.org/10.1073/pnas.2108728118 (2021).
Malin, J. J. et al. SARS-CoV-2 neutralizing antibody treatment in COVID-19 patients with immunodeficiency due to B-cell non-Hodgkin lymphoma. Blood advances; https://doi.org/10.1182/bloodadvances.2021006655 (2021).
Meyer-Arndt, L. et al. Cutting Edge: Serum but Not Mucosal Antibody Responses Are Associated with Pre-Existing SARS-CoV-2 Spike Cross-Reactive CD4+ T Cells following BNT162b2 Vaccination in the Elderly. Journal of immunology 208, 1001–1005; https://doi.org/10.4049/jimmunol.2100990 (2022).
Momsen Reincke, S. et al. SARS-CoV-2 Beta variant infection elicits potent lineage-specific and cross-reactive antibodies. Science (New York, N.Y.), eabm5835; https://doi.org/10.1126/science.abm5835 (2022).
Mühlemann, B. et al. Impact of dexamethasone on SARS-CoV-2 concentration kinetics and antibody response in hospitalised COVID-19 patients - results from a prospective observational study. Clinical microbiology and infection: the official publication of the European Society of Clinical Microbiology and Infectious Diseases; https://doi.org/10.1016/j.cmi.2021.06.008 (2021).
Oestreich, M., Chen, D., Schultze, J. L., Fritz, M. & Becker, M. Privacy considerations for sharing genomics data. EXCLI journal 20, 1243–1260; https://doi.org/10.17179/excli2021-4002 (2021).
Peter, A. S. et al. A pair of non-competing neutralizing human monoclonal antibodies protecting from disease in a SARS-CoV-2 infection model. European journal of immunology; https://doi.org/10.1002/eji.202149374 (2021).
Peter, L. et al. Tacrolimus-resistant SARS-CoV-2-specific T cell products to prevent and treat severe COVID-19 in immunosuppressed patients. Molecular therapy. Methods & clinical development 25, 52–73; https://doi.org/10.1016/j.omtm.2022.02.012 (2022).
Renn, M., Bartok, E., Zillinger, T., Hartmann, G. & Behrendt, R. Animal models of SARS-CoV-2 and COVID-19 for the development of prophylactic and therapeutic interventions. Pharmacology & Therapeutics, 107931; https://doi.org/10.1016/j.pharmthera.2021.107931 (2021).
Ruhl, L. et al. Endothelial dysfunction contributes to severe COVID-19 in combination with dysregulated lymphocyte responses and cytokine networks. Signal transduction and targeted therapy 6, 418; https://doi.org/10.1038/s41392-021-00819-6 (2021).
Schmidt, K. G. et al. SARS-CoV-2-Seronegative Subjects Target CTL Epitopes in the SARS-CoV-2 Nucleoprotein Cross-Reactive to Common Cold Coronaviruses. Frontiers in immunology 12, 627568; https://doi.org/10.3389/fimmu.2021.627568 (2021).
Schrezenmeier, E. et al. Immunogenicity of COVID-19 Tozinameran Vaccination in Patients on Chronic Dialysis. Frontiers in immunology 12, 690698; https://doi.org/10.3389/fimmu.2021.690698 (2021).
Schuh, W. et al. A surrogate cell-based SARS-CoV-2 spike blocking assay. European journal of immunology; https://doi.org/10.1002/eji.202149302 (2021).
Schulz, S. R. et al. Augmented Neutralization of SARS-CoV-2 Omicron Variant by Boost Vaccination and Monoclonal Antibodies. European journal of immunology; https://doi.org/10.1002/eji.202249841 (2022).
Schwarz, T. et al. SARS-CoV-2 Proteome-Wide Analysis Revealed Significant Epitope Signatures in COVID-19 Patients. Frontiers in immunology 12, 629185; https://doi.org/10.3389/fimmu.2021.629185 (2021).
Schwarz, T. et al. Preserved T cell responses to SARS-CoV-2 in anti-CD20 treated multiple sclerosis. Multiple Sclerosis Journal 28; https://doi.org/10.1101/2021.10.11.21264694 (2022).
Schwarz, T. et al. Delayed Antibody and T-Cell Response to BNT162b2 Vaccination in the Elderly, Germany. Emerging infectious diseases 27; https://doi.org/10.3201/eid2708.211145 (2021).
Theobald, S. J. et al. Long–lived macrophage reprogramming drives spike protein–mediated inflammasome activation in COVID–19. EMBO Mol Med; https://doi.org/10.15252/emmm.202114150 (2021).
Thibeault, C. et al. Clinical and virological characteristics of hospitalised COVID-19 patients in a German tertiary care centre during the first wave of the SARS-CoV-2 pandemic: a prospective observational study. Infection; https://doi.org/10.1007/s15010-021-01594-w (2021).
Tober-Lau, P. et al. Cross-Variant Neutralizing Serum Activity after SARS-CoV-2 Breakthrough Infections. Emerging infectious diseases 28; https://doi.org/10.3201/eid2805.220271 (2022).
Tober-Lau, P. et al. Outbreak of SARS-CoV-2 B.1.1.7 Lineage after Vaccination in Long-Term Care Facility, Germany, February-March 2021. Emerging infectious diseases 27; https://doi.org/10.3201/eid2708.210887 (2021).
Tober-Lau, P. et al. Long-term immunogenicity of BNT162b2 vaccination in older people and younger health-care workers. The Lancet Respiratory Medicine 9, e104-e105; https://doi.org/10.1016/S2213-2600(21)00456-2 (2021).
Trimpert, J. et al. Deciphering the Role of Humoral and Cellular Immune Responses in Different COVID-19 Vaccines-A Comparison of Vaccine Candidate Genes in Roborovski Dwarf Hamsters. Viruses 13; https://doi.org/10.3390/v13112290 (2021).
Vanshylla, K. et al. Kinetics and correlates of the neutralizing antibody response to SARS-CoV-2 infection in humans. Cell host & microbe; https://doi.org/10.1016/j.chom.2021.04.015 (2021).
Vanshylla, K. et al. Discovery of ultrapotent broadly neutralizing antibodies from SARS-CoV-2 elite neutralizers. Cell host & microbe; https://doi.org/10.1016/j.chom.2021.12.010 (2021).
Vanshylla, K. et al. Durability of omicron-neutralising serum activity after mRNA booster immunisation in older adults. The Lancet Infectious Diseases 22, 445–446; https://doi.org/10.1016/S1473-3099(22)00135-9 (2022).
Vesper, N. et al. A Barcoded Flow Cytometric Assay to Explore the Antibody Responses Against SARS-CoV-2 Spike and Its Variants. Frontiers in immunology 12, 730766; https://doi.org/10.3389/fimmu.2021.730766 (2021).
Wagner, K. I. et al. Recruitment of highly cytotoxic CD8+ T cell receptors in mild SARS-CoV-2 infection. Cell reports, 110214; https://doi.org/10.1016/j.celrep.2021.110214 (2021).
Warnat-Herresthal, S. et al. Swarm Learning for decentralized and confidential clinical machine learning. Nature; https://doi.org/10.1038/s41586-021-03583-3 (2021).
Wendisch, D. et al. SARS-CoV-2 infection triggers profibrotic macrophage responses and lung fibrosis. Cell 184, 6243-6261.e27; https://doi.org/10.1016/j.cell.2021.11.033 (2021).
Witkowski, M. et al. Untimely TGFβ responses in COVID-19 limit antiviral functions of NK cells. Nature; https://doi.org/10.1038/s41586-021-04142-6 (2021).

DEFEAT PANDEMICs

Heinrich, F.; Roedl, K.; Jarczak, D.; Goebels, H.-L.; Heinemann, A.; Schäfer, U.; Ludwig, F.; Bachmann, M.; Bein, B.;Weber, C.F.; et al. New Insights in the Occurrence of Venous Thromboembolism in Critically Ill Patients with COVID-19—A Large Postmortem and Clinical Analysis. Viruses 2022, 14, 811. https://doi.org/10.3390/v14040811.
Heinrich F, Schröder AS, Gerberding A-L, Gerling M, Langenwalder F, Lange P, Heinemann A, Bibiza-Freiwald E, Nörz DS, Aepfelbacher M, Pfefferle S, Ondruschka B, Lütgehetmann M. Postmortem Antigen-Detecting Rapid Diagnostic Tests to Predict Infectivity of SARS-CoV-2-Associated Deaths. Emerg Infect Dis. 2022;28(1):244–7. doi:10.3201/eid2801.211749.
Zickler M, Stanelle-Bertram S, Ehret S, Heinrich F, Lange P, Schaumburg B, Kouassi NM, Beck S, Jaeckstein MY, Mann O, Krasemann S, Schroeder M, Jarczak D, Nierhaus A, Kluge S, Peschka M, Schlüter H, Renné T, Pueschel K, Kloetgen A, Scheja L, Ondruschka B, Heeren J, Gabriel G. Replication of SARS-CoV-2 in adipose tissue determines organ and systemic lipid metabolism in hamsters and humans. Cell Metab. 2022;34(1):1–2. doi:10.1016/j.cmet.2021.12.002.
Ameratunga R, Woon S-T, Sheppard MN, Garland J, Ondruschka B, Wong CX, Stewart RAH, Tatley M, Stables SR, Tse RD. First Identified Case of Fatal Fulminant Necrotizing Eosinophilic Myocarditis Following the Initial Dose of the Pfizer-BioNTech mRNA COVID-19 Vaccine (BNT162b2, Comirnaty): an Extremely Rare Idiosyncratic Hypersensitivity Reaction. J Clin Immunol. 2022. doi:10.1007/s10875-021-01187-0.
Neidhardt M, Gerlach S, Mieling R, Laves M-H, Weib T, Gromniak M, Fitzek A, Mobius D, Kniep I, Ron A, Schadler J, Heinemann A, Puschel K, Ondruschka B, Schlaefer A. Robotic Tissue Sampling for Safe Post-Mortem Biopsy in Infectious Corpses. IEEE Trans. Med. Robot. Bionics. 2022;4(1):94–105. doi:10.1109/TMRB.2022.3146440.
Jonigk D, Werlein C, Acker T, Aepfelbacher M, Amann KU, Baretton G, Barth P, Bohle RM, Büttner A, Büttner R, Dettmeyer R, Eichhorn P, Elezkurtaj S, Esposito I, Evert K, Evert M, Fend F, Gaßler N, Gattenlöhner S, Glatzel M, Göbel H, Gradhand E, Hansen T, Hartmann A, Heinemann A, Heppner FL, Hilsenbeck J, Horst D, Kamp JC, Mall G, Märkl B, Ondruschka B, Pablik J, Pfefferle S, Quaas A, Radbruch H, Röcken C, Rosenwald A, Roth W, Rudelius M, Schirmacher P, Slotta-Huspenina J, Smith K, Sommer L, Stock K, Ströbel P, Strobl S, Titze U, Weirich G, Weis J, Werner M, Wickenhauser C, Wiech T, Wild P, Welte T, Stillfried S v., Boor P. Organ manifestations of COVID-19: what have we learned so far (not only) from autopsies? Virchows Arch. 2022. doi:10.1007/s00428-022-03319-2.
von Stillfried S, Bülow RD, Röhrig R, Meybohm P, Boor P. Intracranial hemorrhage in COVID-19 patients during extracorporeal membrane oxygenation for acute respiratory failure: a nationwide register study report. Critical care (London, England). 2022;26(1):83. doi:10.1186/s13054-022-03945-x.
Wanner N, Andrieux G, Badia-i-Mompel P, Edler C, Pfefferle S, Lindenmeyer MT, Schmidt-Lauber C, Czogalla J, Wong MN, Okabayashi Y, Braun F, Lütgehetmann M, Meister E, Lu S, Noriega MLM, Günther T, Grundhoff A, Fischer N, Bräuninger H, Lindner D, Westermann D, Haas F, Roedl K, Kluge S, Addo MM, Huber S, Lohse AW, Reiser J, Ondruschka B, Sperhake JP, Saez-Rodriguez J, Boerries M, Hayek SS, Aepfelbacher M, Scaturro P, Puelles VG, Huber TB. Molecular consequences of SARS-CoV-2 liver tropism. Nat Metab. 2022;4(3):310–9. doi:10.1038/s42255-022-00552-6.
Kamp JC, Neubert L, Ackermann M, Stark H, Werlein C, Fuge J, Haverich A, Tzankov A, Steinestel K, Friemann J, Boor P, Junker K, Hoeper MM, Welte T, Laenger F, Kuehnel MP, Jonigk DD. Time-Dependent Molecular Motifs of Pulmonary Fibrogenesis in COVID-19. Int J Mol Sci. 2022;23(3). doi:10.3390/ijms23031583.
Krasemann S, Haferkamp U, Pfefferle S, Woo MS, Heinrich F, Schweizer M, Appelt-Menzel A, Cubukova A, Barenberg J, Leu J, Hartmann K, Thies E, Littau JL, Sepulveda-Falla D, Zhang L, Ton K, Liang Y, Matschke J, Ricklefs F, Sauvigny T, Sperhake J, Fitzek A, Gerhartl A, Brachner A, Geiger N, König E-M, Bodem J, Franzenburg S, Franke A, Moese S, Müller F-J, Geisslinger G, Claussen C, Kannt A, Zaliani A, Gribbon P, Ondruschka B, Neuhaus W, Friese MA, Glatzel M, Pless O. The blood-brain barrier is dysregulated in COVID-19 and serves as a CNS entry route for SARS-CoV-2. Stem Cell Reports. 2022;17(2):307–20. doi:10.1016/j.stemcr.2021.12.011
Von Stillfried S, Bülow RD, Röhrig R, Boor P; German Registry of COVID-19 Autopsies (DeRegCOVID), DeRegCOVID Collaborators. First report from the German COVID-19 autopsy registry, The Lancet Regional Health - Europe, 2022, 100330. doi: 10.1016/j.lanepe.2022.100330.
Brandner JM, Boor P, Borcherding L, Edler C, Gerber S, Heinemann A, Hilsenbeck J, Kasajima A, Lohner L, Märkl B, Pablik J, Schröder AS, Slotta-Huspenina J, Sommer L, Sperhake JP, von Stillfried S, Dintner S. Contamination of personal protective equipment during COVID-19 autopsies. Virchows Arch. 2022 Jan 6:1–10. doi: 10.1007/s00428-021-03263-7. Epub ahead of print.
Ackermann M, Tafforeau P, Wagner WL, Walsh CL, Werlein C, Kühnel MP, Länger FP, Disney C, Bodey AJ, Bellier A, Verleden SE, Lee PD, Mentzer SJ, Jonigk DD. The Bronchial Circulation in COVID-19 Pneumonia. Am J Respir Crit Care Med. 2022 Jan 1;205(1):121-125. doi: 10.1164/rccm.202103-0594IM. PMID: 34734553.
Georg P, Astaburuaga-García R, Bonaguro L, Brumhard S, Michalick L, Lippert LJ, Kostevc T, Gäbel C, Schneider M, Streitz M, Demichev V, Gemünd I, Barone M, Tober-Lau P, Helbig ET, Hillus D, Petrov L, Stein J, Dey HP, Paclik D, Iwert C, Mülleder M, Aulakh SK, Djudjaj S, Bülow RD, Mei HE, Schulz AR, Thiel A, Hippenstiel S, Saliba AE, Eils R, Lehmann I, Mall MA, Stricker S, Röhmel J, Corman VM, Beule D, Wyler E, Landthaler M, Obermayer B, von Stillfried S, Boor P, Demir M, Wesselmann H, Suttorp N, Uhrig A, Müller-Redetzky H, Nattermann J, Kuebler WM, Meisel C, Ralser M, Schultze JL, Aschenbrenner AC, Thibeault C, Kurth F, Sander LE, Blüthgen N, Sawitzki B; PA-COVID-19 Study Group. Complement activation induces excessive T cell cytotoxicity in severe COVID-19. Cell. 2021 Dec 28:S0092-8674(21)01562-2. doi: 10.1016/j.cell.2021.12.040. Epub ahead of print.
Jansen J, Reimer KC, Nagai JS, Varghese FS, Overheul GJ, de Beer M, Roverts R, Daviran D, Fermin LAS, Willemsen B, Beukenboom M, Djudjaj S, von Stillfried S, van Eijk LE, Mastik M, Bulthuis M, Dunnen WD, van Goor H, Hillebrands JL, Triana SH, Alexandrov T, Timm MC, van den Berge BT, van den Broek M, Nlandu Q, Heijnert J, Bindels EMJ, Hoogenboezem RM, Mooren F, Kuppe C, Miesen P, Grünberg K, Ijzermans T, Steenbergen EJ, Czogalla J, Schreuder MF, Sommerdijk N, Akiva A, Boor P, Puelles VG, Floege J, Huber TB; COVID Moonshot consortium, van Rij RP, Costa IG, Schneider RK, Smeets B, Kramann R. SARS-CoV-2 infects the human kidney and drives fibrosis in kidney organoids. Cell Stem Cell. 2021 Dec 25:S1934-5909(21)00520-8. doi: 10.1016/j.stem.2021.12.010. Epub ahead of print.
Walsh CL, Tafforeau P, Wagner WL, Jafree DJ, Bellier A, Werlein C, Kühnel MP, Boller E, Walker-Samuel S, Robertus JL, Long DA, Jacob J, Marussi S, Brown E, Holroyd N, Jonigk DD, Ackermann M, Lee PD. Imaging intact human organs with local resolution of cellular structures using hierarchical phase-contrast tomography. Nat Methods. 2021 Dec;18(12):1532-1541. doi: 10.1038/s41592-021-01317-x. Epub 2021 Nov 4. PMID: 34737453; PMCID: PMC8648561.
Reichardt M, Moller Jensen P, Andersen Dahl V, Bjorholm Dahl A, Ackermann M, Shah H, Länger F, Werlein C, Kuehnel MP, Jonigk D, Salditt T. 3D virtual histopathology of cardiac tissue from Covid-19 patients based on phase-contrast X-ray tomography. Elife. 2021 Dec 21;10:e71359. doi: 10.7554/eLife.71359. Epub ahead of print. PMID: 34930527.
Wendisch D, Dietrich O, Mari T, von Stillfried S, Ibarra IL, Mittermaier M, Mache C, Chua RL, Knoll R, Timm S, Brumhard S, Krammer T, Zauber H, Hiller AL, Pascual-Reguant A, Mothes R, Bülow RD, Schulze J, Leipold AM, Djudjaj S, Erhard F, Geffers R, Pott F, Kazmierski J, Radke J, Pergantis P, Baßler K, Conrad C, Aschenbrenner AC, Sawitzki B, Landthaler M, Wyler E, Horst D; Deutsche COVID-19 OMICS Initiative (DeCOI), Hippenstiel S, Hocke A, Heppner FL, Uhrig A, Garcia C, Machleidt F, Herold S, Elezkurtaj S, Thibeault C, Witzenrath M, Cochain C, Suttorp N, Drosten C, Goffinet C, Kurth F, Schultze JL, Radbruch H, Ochs M, Eils R, Müller-Redetzky H, Hauser AE, Luecken MD, Theis FJ, Conrad C, Wolff T, Boor P, Selbach M, Saliba AE, Sander LE. SARS-CoV-2 infection triggers profibrotic macrophage responses and lung fibrosis. Cell. 2021 Nov 27:S0092-8674(21)01383-0. doi: 10.1016/j.cell.2021.11.033. Epub ahead of print.
Witkowski M, Tizian C, Ferreira-Gomes M, Niemeyer D, Jones TC, Heinrich F, Frischbutter S, Angermair S, Hohnstein T, Mattiola I, Nawrath P, McEwen S, Zocche S, Viviano E, Heinz GA, Maurer M, Kölsch U, Chua RL, Aschman T, Meisel C, Radke J, Sawitzki B, Roehmel J, Allers K, Moos V, Schneider T, Hanitsch L, Mall MA, Conrad C, Radbruch H, Duerr CU, Trapani JA, Marcenaro E, Kallinich T, Corman VM, Kurth F, Sander LE, Drosten C, Treskatsch S, Durek P, Kruglov A, Radbruch A, Mashreghi MF, Diefenbach A. Untimely TGFβ responses in COVID-19 limit antiviral functions of NK cells. Nature. 2021 Dec;600(7888):295-301. doi: 10.1038/s41586-021-04142-6. Epub 2021 Oct 25.
Bräuninger H, Stoffers B, Fitzek ADE, Meißner K, Aleshcheva G, Schweizer M, Weimann J, Rotter B, Warnke S, Edler C, Braun F, Roedl K, Scherschel K, Escher F, Kluge S, Huber TB, Ondruschka B, Schultheiss HP, Kirchhof P, Blankenberg S, Püschel K, Westermann D, Lindner D. Cardiac SARS-CoV-2 infection is associated with pro-inflammatory transcriptomic alterations within the heart. Cardiovasc Res. 2021 Oct 14:cvab322. doi: 10.1093/cvr/cvab322. Epub ahead of print. PMID: 34647998.
von Stillfried S, Boor P; DeRegCOVID und DEFEAT PANDEMIcs. Entwicklung eines kooperativen Obduktionsnetzwerks aus Pathologie, Neuropathologie und Rechtsmedizin [Development of a cooperative autopsy network of pathology, neuropathology and forensic medicine]. Pathologe. 2021 Oct 29:1–5. German. doi: 10.1007/s00292-021-01004-w. Epub ahead of print. PMID: 34714353; PMCID: PMC8554747.
Wenzel J, Lampe J, Müller-Fielitz H, Schuster R, Zille M, Müller K, Krohn M, Körbelin J, Zhang L, Özorhan Ü, Neve V, Wagner JUG, Bojkova D, Shumliakivska M, Jiang Y, Fähnrich A, Ott F, Sencio V, Robil C, Pfefferle S, Sauve F, Coêlho CFF, Franz J, Spiecker F, Lembrich B, Binder S, Feller N, König P, Busch H, Collin L, Villaseñor R, Jöhren O, Altmeppen HC, Pasparakis M, Dimmeler S, Cinatl J, Püschel K, Zelic M, Ofengeim D, Stadelmann C, Trottein F, Nogueiras R, Hilgenfeld R, Glatzel M, Prevot V, Schwaninger M. The SARS-CoV-2 main protease Mpro causes microvascular brain pathology by cleaving NEMO in brain endothelial cells. Nat Neurosci. 2021 Nov;24(11):1522-1533. doi: 10.1038/s41593-021-00926-1. Epub 2021 Oct 21. PMID: 34675436; PMCID: PMC8553622.
Berezowska S, Boor P, Jonigk D, Tischler V. [Update on thoracic pathology 2021-report of the working group thoracic pathology of the German Society of Pathology]. Pathologe. 2021 Oct 5;1-4. doi: 10.1007/s00292-021-00991-0.
Walsh C, Tafforeau P, Wagner WL, Jafree DJ, Bellier A, Werlein C, Kühnel MP, Boller E, Walker-Samuel S, Robertus JL, Long DA, Jacob J, Marussi S, Brown E, Holroyd N, Jonigk DD, Ackermann M, Lee PD. Multiscale three-dimensional imaging of intact human organs down to the cellular scale using hierarchical phase-contrast tomography. bioRxiv [Preprint]. 2021 Feb 3:2021.02.03.429481. doi: 10.1101/2021.02.03.429481. Update in: Nat Methods. 2021 Nov 4;: PMID: 33564772; PMCID: PMC7872374.
Lehmann M, Allers K, Heldt C, Meinhardt J, Schmidt F, Rodriguez-Sillke Y, Kunkel D, Schumann M, Böttcher C, Stahl-Hennig C, Elezkurtaj S, Bojarski C, Radbruch H, Corman VM, Schneider T, Loddenkemper C, Moos V, Weidinger C, Kühl AA, Siegmund B. Human small intestinal infection by SARS-CoV-2 is characterized by a mucosal infiltration with activated CD8+ T cells. Mucosal Immunol. 2021 Aug 21:1–12. doi: 10.1038/s41385-021-00437-z. Epub ahead of print. PMID: 34420043; PMCID: PMC8379580.
Schwabenland M, Salié H, Tanevski J, Killmer S, Lago MS, Schlaak AE, Mayer L, Matschke J, Püschel K, Fitzek A, Ondruschka B, Mei HE, Boettler T, Neumann-Haefelin C, Hofmann M, Breithaupt A, Genc N, Stadelmann C, Saez-Rodriguez J, Bronsert P, Knobeloch KP, Blank T, Thimme R, Glatzel M, Prinz M, Bengsch B. Deep spatial profiling of human COVID-19 brains reveals neuroinflammation with distinct microanatomical microglia-T-cell interactions. Immunity. 2021 Jul 13;54(7):1594-1610.e11. doi: 10.1016/j.immuni.2021.06.002. Epub 2021 Jun 9. PMID: 34174183; PMCID: PMC8188302.
O'Hare M, Amarnani D, Whitmore HAB, An M, Marino C, Ramos L, Delgado-Tirado S, Hu X, Chmielewska N, Chandrahas A, Fitzek A, Heinrich F, Steurer S, Ondruschka B, Glatzel M, Krasemann S, Sepulveda-Falla D, Lagares D, Pedron J, Bushweller JH, Liu P, Arboleda-Velasquez JF, Kim LA. Targeting Runt-Related Transcription Factor 1 Prevents Pulmonary Fibrosis and Reduces Expression of Severe Acute Respiratory Syndrome Coronavirus 2 Host Mediators. Am J Pathol. 2021 Jul;191(7):1193-1208. doi: 10.1016/j.ajpath.2021.04.006. Epub 2021 Apr 21. PMID: 33894177; PMCID: PMC8059259.
Edler C, Klein A, Schröder AS, Sperhake JP, Ondruschka B. Deaths associated with newly launched SARS-CoV-2 vaccination (Comirnaty®). Leg Med (Tokyo). 2021 Jul;51:101895. doi: 10.1016/j.legalmed.2021.101895. Epub 2021 Apr 17. PMID: 33895650; PMCID: PMC8052499.
Gerlach S, Neidhardt M, Weiß T, Laves MH, Stapper C, Gromniak M, Kniep I, Möbius D, Heinemann A, Ondruschka B, Schlaefer A. Needle insertion planning for obstacle avoidance in robotic biopsy. Current Directions in Biomedical Engineering. 2021;7(2): 779-782. doi: 10.1515/cdbme-2021-2199
Aschman T, Schneider J, Greuel S, Meinhardt J, Streit S, Goebel HH, Büttnerova I, Elezkurtaj S, Scheibe F, Radke J, Meisel C, Drosten C, Radbruch H, Heppner FL, Corman VM, Stenzel W. Association Between SARS-CoV-2 Infection and Immune-Mediated Myopathy in Patients Who Have Died. JAMA Neurol. 2021 Aug 1;78(8):948-960. doi: 10.1001/jamaneurol.2021.2004. PMID: 34115106.
Fitzek A, Schädler J, Dietz E, Ron A, Gerling M, Kammal AL, Lohner L, Falck C, Möbius D, Goebels H, Gerberding AL, Schröder AS, Sperhake JP, Klein A, Fröb D, Mushumba H, Wilmes S, Anders S, Kniep I, Heinrich F, Langenwalder F, Meißner K, Lange P, Zapf A, Püschel K, Heinemann A, Glatzel M, Matschke J, Aepfelbacher M, Lütgehetmann M, Steurer S, Thorns C, Edler C, Ondruschka B. Prospective postmortem evaluation of 735 consecutive SARS-CoV-2-associated death cases. Sci Rep. 2021 Sep 29;11(1):19342. doi: 10.1038/s41598-021-98499-3.
Swoboda J, Wittschieber D, Sanft J, Kleemann S, Elschner S, Ihle H, Hubig M, Pletz MW, Mall G, Gassler N. Bone marrow haemophagocytosis indicates severe infection with severe acute respiratory syndrome coronavirus 2. Histopathology. 2021 Apr;78(5):727-737. doi: 10.1111/his.14281. Epub 2020 Dec 18. PMID: 33067892.
Ricke-Hoch M, Stelling E, Lasswitz L, Gunesch AP, Kasten M, Zapatero-Belinchón FJ, Brogden G, Gerold G, Pietschmann T, Montiel V, Balligand JL, Facciotti F, Hirsch E, Gausepohl T, Elbahesh H, Rimmelzwaan GF, Höfer A, Kühnel MP, Jonigk D, Eigendorf J, Tegtbur U, Mink L, Scherr M, Illig T, Schambach A, Pfeffer TJ, Hilfiker A, Haverich A, Hilfiker-Kleiner D. Impaired immune response mediated by prostaglandin E2 promotes severe COVID-19 disease. PLoS One. 2021 Aug 4;16(8):e0255335. doi: 10.1371/journal.pone.0255335. PMID: 34347801; PMCID: PMC8336874.
Ackermann M, Jonigk DD. Microvascular placental alterations in maternal COVID-19. Am J Obstet Gynecol. 2021 Jul 3:S0002-9378(21)00782-1. doi: 10.1016/j.ajog.2021.06.098. Epub ahead of print. PMID: 34228972; PMCID: PMC8254388.
Althaus K, Möller P, Uzun G, Singh A, Beck A, Bettag M, Bösmüller H, Guthoff M, Dorn F, Petzold GC, Henkes H, Heyne N, Jumaa H, Kreiser K, Limpach C, Luz B, Maschke M, Müller JA, Münch J, Nagel S, Pötzsch B, Müller J, Schlegel C, Viardot A, Bäzner H, Wolf M, Pelzl L, Warm V, Willinek WA, Steiner J, Schneiderhan-Marra N, Vollherbst D, Sachs UJ, Fend F, Bakchoul T. Antibody-mediated procoagulant platelets in SARS-CoV-2-vaccination associated immune thrombotic thrombocytopenia. Haematologica. 2021 Aug 1;106(8):2170-2179. doi: 10.3324/haematol.2021.279000.
Ondruschka B, Heinrich F, Lindenmeyer M, Edler C, Möbius D, Czogalla J, Heinemann A, Braun F, Aepfelbacher M, Lütgehetmann M, Huber TB. Multiorgan tropism of SARS-CoV-2 lineage B.1.1.7. Int J Legal Med. 2021 Sep 6:1–3. doi: 10.1007/s00414-021-02691-z. Epub ahead of print. PMID: 34486072; PMCID: PMC8418960.
Gagiannis D, Umathum VG, Bloch W, Rother C, Stahl M, Witte HM, Djudjaj S, Boor P, Steinestel K. Antemortem vs Postmortem Histopathologic and Ultrastructural Findings in Paired Transbronchial Biopsy Specimens and Lung Autopsy Samples From Three Patients With Confirmed SARS-CoV-2. Am J Clin Pathol. 2021. doi: 10.1093/ajcp/aqab087. Epub ahead of print.
Wong DWL, Klinkhammer BM, Djudjaj S, Villwock S, Timm MC, Buhl EM, Wucherpfennig S, Cacchi C, Braunschweig T, Knüchel-Clarke R, Jonigk D, Werlein C, Bülow RD, Dahl E, von Stillfried S, Boor P. Multisystemic Cellular Tropism of SARS-CoV-2 in Autopsies of COVID-19 Patients. Cells. 2021;10(8):1900. doi: 10.3390/cells10081900.
von Stillfried S, Villwock S, Bülow RD, Djudjaj S, Buhl EM, Maurer A, Ortiz-Brüchle N, Celec P, Klinkhammer BM, Wong DWL, Cacchi C, Braunschweig T, Knüchel-Clarke R, Dahl E, Boor P. SARS-CoV-2 RNA screening in routine pathology specimens. Microb Biotechnol. 2021 Jul;14(4):1627-1641. doi: 10.1111/1751-7915.13828. Epub 2021 May 16.
Heinrich F, Romich C, Zimmermann T, Kniep I, Fitzek A, Steurer S, Glatzel M, Nörz D, Günther T, Czech-Sioli M, Fischer N, Grundhoff A, Lütgehetmann M, Ondruschka B. Dying of VOC-202012/01 - multimodal investigations in a death case of the SARS-CoV-2 variant. Int J Legal Med. 2021 5:1–10. doi: 10.1007/s00414-021-02618-8.
Althaus K, Möller P, Uzun G, Singh A, Beck A, Bettag M, Bösmüller H, Guthoff M, Dorn F, Petzold GC, Henkes H, Heyne N, Jumaa H, Kreiser K, Limpach C, Luz B, Maschke M, Müller JA, Münch J, Nagel S, Pötzsch B, Müller J, Schlegel C, Viardot A, Bäzner H, Wolf M, Pelzl L, Warm V, Willinek WA, Steiner J, Schneiderhan-Marra N, Vollherbst D, Sachs UJ, Fend F, Bakchoul T. Antibody-mediated procoagulant platelets in SARS-CoV-2- vaccination associated immune thrombotic thrombocytopenia. Haematologica. 2021 20. doi: 10.3324/haematol.2021.279000
Roedl K, Heidenreich S, Pfefferle S, Jarczak D, Urbanowicz TT, Nörz D, Aepfelbacher M, Kröger N, Kluge S, Lütgehetmann M, Christopeit M, Wichmann D. Viral Dynamics of SARS-CoV-2 in Critically Ill Allogeneic Hematopoietic Stem Cell Transplant Recipients and Immunocompetent Patients with COVID-19. Am J Respir Crit Care Med. 2021 15;203(2):242-245. doi: 10.1164/rccm.202009-3386LE.
Klein A, Langenwalder F, Heinrich F, Meißner K, Schröder AS, Püschel K, Ondruschka B, Lütgehetmann M, Heinemann A. SARS-CoV2-Zufallsentdeckungen bei Hamburger Todesfällen: ein epidemiologisches Monitoring während des dynamischen Infektionsgeschehens im Frühjahr 2020 [SARS-CoV2 incidental findings among Hamburg deaths: an epidemiological monitoring during the dynamic infection event in spring 2020]. Rechtsmedizin (Berl). 2021 20:1-7. German. doi: 10.1007/s00194-021-00481-w.
Glatzel M, Hagel C, Matschke J, Sperhake J, Deigendesch N, Tzankov A, Frank S. Neuropathology associated with SARS-CoV-2 infection. Lancet. 2021 23;397(10271):276. doi: 10.1016/S0140-6736(21)00098-2.
Lohner L, Fröb D, Edler C, Schröder AS, Dietz E, Ondruschka B. SARS-CoV-2-assoziierte Todesfälle von erwachsenen Personen bis 50 Jahre: Eine retrospektive Auswertung der COVID-19-assoziierten Todesfälle im Jahr 2020 im Institut für Rechtsmedizin Hamburg, Deutschland [SARS-CoV-2-associated deaths in adult persons up to 50 years of age]. Rechtsmedizin (Berl). 2021 13:1-9. German. doi: 10.1007/s00194-021-00483-8.
Casagrande M, Fitzek A, Spitzer M, Püschel K, Glatzel M, Krasemann S, Aepfelbacher M, Nörz D, Lütgehetmann M, Pfefferle S, Schultheiss M. Detection of SARS-CoV-2 genomic and subgenomic RNA in retina and optic nerve of patients with COVID-19. Br J Ophthalmol. 2021 9:bjophthalmol-2020-318618. doi: 10.1136/bjophthalmol-2020-318618.
Zack F, Nigbur S, Manhart J, Derani H, Boy D, Kolbe V, Büttner A. Erste Ergebnisse der Obduktionen der im Zusammenhang mit den SARS-CoV-2-Infektionen Verstorbenen aus der Unimedizin Rostock. Ärztebl Meckl-Vorpom. 2021; 31:125-128.
Ackermann M, Werlein C, Länger F, Kühnel MP, Jonigk DD. COVID-19: Auswirkungen auf Lunge und Herz [COVID-19: effects on the lungs and heart]. Pathologe. 2021; 42(2):164-171. German. doi: 10.1007/s00292-021-00918-9.
Amann K, Boor P, Wiech T, Singh J, Vonbrunn E, Knöll A, Hermann M, Büttner-Herold M, Daniel C, Hartmann A. COVID-19-Auswirkungen auf die Niere [COVID-19 effects on the kidney]. Pathologe. 2021; 42(2):183-187. German. doi: 10.1007/s00292-020-00899-1.
Boor P, Eichhorn P, Hartmann A, Lax SF, Märkl B, Menter T, Skok K, Slotta-Huspenina J, von Stillfried S, Tzankov A, Weirich G. Praktische Aspekte von COVID-19-Obduktionen [Practical aspects of COVID-19 autopsies]. Pathologe. 2021; 42(2):197-207. German. doi: 10.1007/s00292-021-00925-w.
Roth W, Boor P. COVID-19 im Spiegel der Pathologie [COVID-19 in the mirror of pathology]. Pathologe. 2021; 42(2):147-148. German. doi: 10.1007/s00292-021-00916-x.
Strobl S, Roth W. Internationale wissenschaftliche Publikationsaktivität zu COVID-19 [International publication activity during the COVID-19 pandemic]. Pathologe. 2021; 42(2):224-230. German. doi: 10.1007/s00292-020-00892-8.
Traxler S, Schindler M, Bösmüller H, Klingel K. Biologie und Pathologie von Coronaviren [Biology and pathology of coronaviruses]. Pathologe. 2021; 42(2):149-154. German. doi: 10.1007/s00292-021-00923-y.
von Stillfried S, Acker T, Aepfelbacher M, Baretton G, Bülow RD, Bürrig KF, Holtherm HU, Jonigk D, Knüchel R, Majeed RW, Röhrig R, Wienströer J, Boor P. Kooperatives Vorgehen der Pathologie und Neuropathologie in der COVID-19-Pandemie : Deutsches Register für COVID-19-Obduktionen (DeRegCOVID) und Deutsches Netzwerk für Autopsien in Pandemien (DEFEAT PANDEMIcs) [Cooperative approach of pathology and neuropathology in the COVID-19 pandemic : German registry for COVID-19 autopsies (DeRegCOVID) and German network for autopsies in pandemics (DEFEAT PANDEMIcs)]. Pathologe. 2021; 42(2):216-223. German. doi: 10.1007/s00292-020-00891-9.
von Stillfried S, Boor P. Nachweismethoden von SARS-CoV-2 in Gewebe [Methods of SARS-CoV-2 detection in tissue]. Pathologe. 2021; 42(2):208-215. German. doi: 10.1007/s00292-021-00919-8.
Englisch CN, Tschernig T, Flockerzi F, Meier C, Bohle RM. Lesions in the lungs of fatal corona virus disease Covid-19. Ann Anat. 2021; 234:151657. doi: 10.1016/j.aanat.2020.151657.
Nicolai L, Leunig A, Brambs S, Kaiser R, Joppich M, Hoffknecht ML, Gold C, Engel A, Polewka V, Muenchhoff M, Hellmuth JC, Ruhle A, Ledderose S, Weinberger T, Schulz H, Scherer C, Rudelius M, Zoller M, Keppler OT, Zwißler B, von Bergwelt-Baildon M, Kääb S, Zimmer R, Bülow RD, von Stillfried S, Boor P, Massberg S, Pekayvaz K, Stark K. Vascular neutrophilic inflammation and immunothrombosis distinguish severe COVID-19 from influenza pneumonia. J Thromb Haemost. 2021;19(2):574-581. doi: 10.1111/jth.15179
Casagrande M, Fitzek A, Spitzer MS, Püschel K, Glatzel M, Krasemann S, Nörz D, Lütgehetmann M, Pfefferle S, Schultheiss M. Presence of SARS-CoV-2 RNA in the Cornea of Viremic Patients With COVID-19. JAMA Ophthalmol. 2021 21:e206339. doi: 10.1001/jamaophthalmol.2020.6339.
Evert K, Dienemann T, Brochhausen C, Lunz D, Lubnow M, Ritzka M, Keil F, Trummer M, Scheiter A, Salzberger B, Reischl U, Boor P, Gessner A, Jantsch J, Calvisi DF, Evert M, Schmidt B, Simon M. Autopsy findings after long-term treatment of COVID-19 patients with microbiological correlation. Virchows Arch. 2021 20:1–12. doi: 10.1007/s00428-020-03014-0.
Heinrich F, Meißner K, Langenwalder F, Püschel K, Nörz D, Hoffmann A, Lütgehetmann M, Aepfelbacher M, Bibiza-Freiwald E, Pfefferle S, Heinemann A. Postmortem Stability of SARS-CoV-2 in Nasopharyngeal Mucosa. Emerg Infect Dis. 2021;27(1):329–31. doi: 10.3201/eid2701.203112.
Janíková M, Hodosy J, Boor P, Klempa B, Celec P. Loop-mediated isothermal amplification for the detection of SARS-CoV-2 in saliva. Microb Biotechnol. 2021;14(1):307-316. doi: 10.1111/1751-7915.13737.
Subbarayan K, Ulagappan K, Wickenhauser C, Seliger B. Expression and clinical significance of SARS-CoV-2 human targets in neoplastic and non-neoplastic lung tissues. Curr Cancer Drug Targets. 2020 7. doi: 10.2174/1568009620666201207145019.
Bojkova D, Wagner JUG, Shumliakivska M, Aslan GS, Saleem U, Hansen A, Luxán G, Günther S, Pham MD, Krishnan J, Harter PN, Ermel UH, Frangakis AS, Milting H, Zeiher AM, Klingel K, Cinatl J, Dendorfer A, Eschenhagen T, Tschöpe C, Ciesek S, Dimmeler S. SARS-CoV-2 infects and induces cytotoxic effects in human cardiomyocytes. Cardiovasc Res. 2020 1;116(14):2207-2215. doi: 10.1093/cvr/cvaa267.
Boor P, Hartmann A. Bericht zur Late-Breaking Session Pathologie und COVID-19 [Late Breaking Session Pathology and COVID-19 Report]. Pathologe. 2020; 41(Suppl 2):96-98. German. doi: 10.1007/s00292-020-00882-w
Gagiannis D, Steinestel J, Hackenbroch C, Schreiner B, Hannemann M, Bloch W, Umathum VG, Gebauer N, Rother C, Stahl M, Witte HM, Steinestel K. Clinical, Serological, and Histopathological Similarities Between Severe COVID-19 and Acute Exacerbation of Connective Tissue Disease-Associated Interstitial Lung Disease (CTD-ILD). Front Immunol. 2020 2;11:587517. doi: 10.3389/fimmu.2020.587517.

Egepan Unimed

Abdel-Karim, B. M., Pfeuffer, N., Rohde, G., & Hinz, O. (2020). How and What Can Hu- mans Learn from Being in the Loop? KI - Künstliche Intelligenz, 34(2), 199–207. https://doi.org/10.1007/s13218-020-00638-x
Adorjan, K., Pogarell, O., Pröbstl, L., Rüb, M., Wiegand, H. F., Tüscher, O., Lieb, K., Wassili- wizky, M., Gerlinger, G., Heinz, A., & Falkai, P. (2021). Auswirkungen der COVID-19-Pan- demie auf die Versorgungssituation in psychiatrischen Kliniken in Deutschland. Der Ner- venarzt, 92(6), 562–570. https://doi.org/10.1007/s00115-021-01129-6
Ahrens, K. F., Neumann, R. J., Kollmann, B., Brokelmann, J., von Werthern, N. M., Malys- hau, A., Weichert, D., Lutz, B., Fiebach, C. J., Wessa, M., Kalisch, R., Plichta, M. M., Lieb, K., Tüscher, O., & Reif, A. (2021). Impact of COVID-19 lockdown on mental health in Ger- many: Longitudinal observation of different mental health trajectories and protective fac- tors. Translational Psychiatry, 11(1), 1–10. https://doi.org/10.1038/s41398-021-01508-2
Ahrens, K. F., Neumann, R. J., Kollmann, B., Plichta, M. M., Lieb, K., Tüscher, O., & Reif, A. (2021). Differential impact of COVID-related lockdown on mental health in Germany. World Psychiatry, 20(1), 140–141. https://doi.org/10.1002/wps.20830
Baldinger, M., Heinrich, A., Adams, T., Martens, E., Dommasch, M., Muller, A., Siegmann, A., Schmidt, G., Amft, O., & Laerhoven, K. V. (2021). TELECOVID: Remote Vital Signs Moni- toring of COVID-19 Risk Patients in Home Isolation With an In-Ear Wearable. IEEE Per- vasive Computing, 20(2), 58–62. https://doi.org/10.1109/MPRV.2021.3066825
Bartels, C., Hessmann, P., Schmidt, U., Vogelgsang, J., Ruhleder, M., Kratzenberg, A., Trep- tow, M., Reh-Bergen, T., Abdel-Hamid, M., Heß, L., Meiser, M., Signerski-Krieger, J., Ra- denbach, K., Trost, S., Schott, B. H., Wiltfang, J., Wolff-Menzler, C., & Belz, M. (2021). Me- dium-term and peri-lockdown course of psychosocial burden during the ongoing
COVID-19 pandemic: A longitudinal study on patients with pre-existing mental disorders. European Archives of Psychiatry and Clinical Neuroscience. https://doi.org/10.1007/s00406-021-01351-y
Bauer, S., Contreras, S., Dehning, J., Linden, M., Iftekhar, E., Mohr, S. B., Olivera-Nappa, A., & Priesemann, V. (2021b). Relaxing restrictions at the pace of vaccination increases free- dom and guards against further COVID-19 waves. PLOS Computational Biology, 17(9), e1009288. https://doi.org/10.1371/journal.pcbi.1009288
Baumann M, (2021) COVID-19 and mental health in children and adolescents: a diagnos- tic panel to map psycho-social consequences in the pandemic context, Discov Ment Health, 2021, 1(1):2 doi: 10.1007/s44192-021-00002-x.
Baumann, M., Berghäuser, M., Bolz, T. & Martens, T. (2021). Den Fokus neu denken - Skizze eines Pandemiemanagements auf Grundlage der Bedürfnisse und Lern- und Ent- wicklungserfordernissen von Kindern, Jugendlichen und Familien, Verfügbar unter: https://www.socialnet.de/materialien/29164.php
Beschoner P, Jarczok MN, Kempf M, Weimer K, Geiser F, Hiebel N, Erim Y, Morawa E, Steudte-Schmiedgen S, Albus C, Jerg-Bretzke L. [egePan-VOICE study on the psychoso- cial burden of the Covid-19 pandemic among - medical technical assistants]. Z Psycho- som Med Psychother. 2021 Dec 10:OA15.
Borusiak P, Mazheika Y, Bauer S, Haberlandt E, Krois I, Fricke C, Simon L, Beschoner P, Jerg-Bretzke L, Geiser F, Hiebel N, Weidner K, Albus C, Morawa E, Erim Y. The impact of the COVID-19 pandemic on pediatric developmental services: a cross-sectional study on overall burden and mental health status. Arch Public Health. 2022 Apr 8;80(1):113. On- line verfügbar unter: https://www.ncbi.nlm.nih.gov/pmc/artic- les/PMC8990278/pdf/13690_2022_Article_876.pd
Clemens, V., Beschoner, P., Jarczok, M. N., Weimer, K., Kempf, M., Morawa, E., Geiser, F., Albus, C., Steudte-Schmiedgen, S., Gündel, H., Fegert, J. M., & Jerg-Bretzke, L. (o. J.) (2021). The mediating role of COVID-19-related burden in the association between ad- verse childhood experiences and emotional exhaustion: Results of the egePan – VOICE study. European Journal of Psychotraumatology, 12(1), 1976441. https://doi.org/10.1080/20008198.2021.1976441
Contreras, S., Dehning, J., Mohr, S. B., Bauer, S., Spitzner, F. P., & Priesemann, V. (2021). Low case numbers enable long-term stable pandemic control without lockdowns. Sci- ence advances, 7(41), eabg2243. https://doi.org/10.1126/sciadv.abg2243
Cramer, K. et al. (May 2021). Border Restrictions and Cross-Border Care Relations: The Case of Germany and Vietnam. Working Paper Series: Politics of Pandemic Care, No. 2.
Cramer, K. et al. (April 2021). Exploring Disruption and Response in International Cross- Country Comparison. Working Paper Series: Politics of Pandemic Care, No. 1.
Czypionka, T., Iftekhar, E. N., Prainsack, B., Priesemann, V., Bauer, S., Valdez, A. C., Cus- chieri, S., Glaab, E., Grill, E., Krutzinna, J., Lionis, C.; Machado, H, Martins, C., Pavlakis G.N., Perc, M., Petelos, E., Pickersgill, M., Skupin, A., Schernhammer, E., Szczurek, E, Tsiodras, S., Willeit, P., Wilmes, P. (2022). The benefits, costs and feasibility of a low incidence COVID- 19 strategy. The Lancet Regional Health-Europe, 13, 100294. doi.org/10.1016/j.lanepe.2021.100294
Dauletbaev, N., Kuhn, S., Holtz, S., Waldmann, S., Niekrenz, L., Müller, B. S., Bellinghausen, C., Dreher, M., Rohde, G. G. U., & Vogelmeier, C. (2021). Implementation and use of mHealth home telemonitoring in adults with acute COVID-19 infection: A scoping review protocol. BMJ Open, 11(9), e053819. https://doi.org/10.1136/bmjopen-2021-053819
Dönges. P., Wagner, J., Contreras, S., Iftekhar, E. N., Bauer, S., Mohr, S. B., Dehning, J., Va- ldez, A. C., Kretzschmar, M.; Mäs. M., Nagel, K., Priesemann, V. (2022). Interplay Between Risk Perception, Behavior, and COVID-19 Spread. Frontiers in Physics, 10, 842180. doi.org/10.3389/fphy.2022.842180
Döpfner, M., Adam, J., Habbel, C., Schulte, B., Schulze-Husmann, K., Simons, M., Heuer, F., Wegner, C., Bender, S., Döpfner, M., Adam, J., Habbel, C., Schulze-Husmann, K., Simons, M., Schwendowius, J., Heuer, F., Wegner, C., Bender, S., Herpertz-Dahlmann, B., … B-FAST- Studiengruppe. (2021). Die psychische Belastung von Kindern, Jugendlichen und ihren Familien während der COVID-19-Pandemie und der Zusammenhang mit emotionalen und Verhaltensauffälligkeiten. Bundesgesundheitsblatt - Gesundheitsforschung - Ge- sundheitsschutz, 64(12), 1522–1532. https://doi.org/10.1007/s00103-021-03455-1
Eggers, D. Best practice models for nursing care in the COVID-19-pandemic: a web-based survey. Joint Scientific Summer Conference DGP/EANS. Lessons learned from the pan- demic in different nursing settings. 02.07.2021. Vortrag.
Geraedts, M., Eberlein-Gonska, M., Hecker, R., Schneider, K., Schroeder-Printzen, I., & Zeuner, M. (2021). Stationäre Versorgung: Empfehlungen für ein künftiges Pandemiema- nagement. Dtsch Arztebl International, 118(19–20), A-991.
Hannemann J, Abdalrahman A, Erim Y, Morawa E, Jerg-Bretzke L, Beschoner P, Geiser F, Hiebel N, Weidner K, Steudte-Schmiedgen S, Albus C. (2022) The impact of the COVID-19 pandemic on the mental health of medical staff considering the interplay of pandemic burden and psychosocial resources-A rapid systematic review. PLoS One. 2022 Feb 22;17(2):e0264290. Online verfügbar unter: https://www.ncbi.nlm.nih.gov/pmc/artic-les/PMC8863237/pdf/pone.0264290.pdf
Holz, J. (February 2021). Singapurs gebrochenes Versprechen, in: Südostasien. Zeitschrift für Politik, Kultur, Dialog. Online available: suedostasien.net/singapurs-gebroche- nes-versprechen/
Holz, J. (February 2021). Der Erfolg Vietnams im Kampf gegen das Virus, in: Südostasien. Zeitschrift für Politik, Kultur, Dialog. Online available: suedostasien.net/der-erfolg- vietnams-im-kampf-gegen-das-virus/
Iftekhar, E. N., Priesemann, V., Balling, R., Bauer, S., Beutels, P., Valdez, A. C., Cuschieri, S., Czypionla, T., Dumpis, U., Glaab, E., Grill, E., Hanson, C., Hotulainen, P., Klimek, P., Kretz- schmar, M., Krüger, T., Krutzinna, J., Low, N., Machado, H., Martins, C., McKee, M., Mohr, S. B., Nassehi, A., Perc, M., Petelos, E., Pickersgrill, M., Prainsack, B., Rocklöv, J., Schernham- mer, E., Staines, A., Szczurek, E., Tsiodras, S., Van Gucht, S., Willeit, P. (2021). A look into the future of the COVID-19 pandemic in Europe: an expert consultation. The Lancet Re- gional Health-Europe, 8, 100185. doi.org/10.1016/j.lanepe.2021.100185
Jerg-Bretzke, L., Kempf, M., Jarczok, M. N., Weimer, K., Hirning, C., Gündel, H., Erim, Y., Morawa, E., Geiser, F., Hiebel, N., Weidner, K., Albus, C., & Beschoner, P. (2021). Psychoso- cial Impact of the COVID-19 Pandemic on Healthcare Workers and Initial Areas of Action for Intervention and Prevention—The egePan/VOICE Study. International Journal of Envi- ronmental Research and Public Health, 18(19), 10531. https://doi.org/10.3390/ijerph181910531
Layer E, Hoehl S, Widera M, Bojkova D, Westphal T, Gottschalk R, Boeddinghaus B, Schork J, Ciesek S, Goetsch U; SARS-CoV-2 screening strategies for returning interna- tional travellers: Evaluation of a rapid antigen test approach, Int J Infect Dis, 2022 Mar 2;118:126-131. doi: 10.1016/j.ijid.2022.02.045.
Lowin, M., & Kellner, D. (2021). From Twitter to COVID-19: Using NLP to Predict COVID- 19 Infections. PACIS 2021 Proceedings. https://aisel.aisnet.org/pacis2021/147
Mayer, M. und K. Cramer (2022). Pandemic Disruptions and Transnational Care Relations: Towards Closing the “Care Gap” in International Relations Theories. In: In the Realm of Corona Normativities II, Gephart, W. (ed.), Verlag Vitorrio Klostermann.
Mayer, M., Kunhan, L. und Zhu, M. (2020). China, in: Sheila Jasanoff et al. (eds.): Compara- tive Covid Response: Crisis, Knowledge, Politics. Online verfügbar: assets.website- files.com/5fdfca1c14b4b91eeaa7196a/5ffda00d50fca2e6f8782aed_Harvard-Cor- nell%20Report%202020.pdf
Morawa, E., Schug, C., Geiser, F., Beschoner, P., Jerg-Bretzke, L., Albus, C., Weidner, K., Hiebel, N., Borho, A., & Erim, Y. (2021). Psychosocial burden and working conditions dur- ing the COVID-19 pandemic in Germany: The VOICE survey among 3678 health care workers in hospitals. Journal of Psychosomatic Research, 144, 110415. https://doi.org/10.1016/j.jpsychores.2021.110415.
Müller, A. (2021). Plattform für die transsektiorale Kommunikation im regionalen Pande- miemanagement. Miracum, Spring School 2021: „IT-Unterstützung in der Corona-Pande- mie“, online. 06.05.2021.
Müller, A (2021). Implementierung einer Kommunikationsplattform für die transsektorale Vernetzung im regionalen Pandemiemanagement (KomPan-Studie). DMEA, Connecting Digital Health, Online. 07.06.2021.
Müller, A., Engler, F., Schütze, D., Nohl-Deryk, P., & Güthlin, C. (2021). Communication ex- perience by secure instant messaging during the Covid-19 pandemic for general practi- tioners and public health workers – a qualitative analysis. Doc21dkvf051. https://doi.org/10.3205/21dkvf051
Müller, A., Haneke, H., Kirchberger, V., Mastella, G., Dommasch, M., Merle, U., Heinze, O., Siegmann, A., Spinner, C., Buiatti, A., Laugwitz, K.-L., Schmidt, G., & Martens, E. (2022). In- tegration of mobile sensors in a telemedicine hospital system: Remote-monitoring in COVID-19 patients. Journal of Public Health, 30(1), 93–97. https://doi.org/10.1007/s10389-021-01655-2
Müller, A., Melzow, F. S., Göstemeyer, G., Paris, S., & Schwendicke, F. (2021). Implementa- tion of COVID-19 Infection Control Measures by German Dentists: A Qualitative Study to Identify Enablers and Barriers. International Journal of Environmental Research and Public Health, 18(11), 5710. https://doi.org/10.3390/ijerph18115710
Müller, A., Nohl-Deryk, P. & Guethlin , C. (2021). Veränderung der Kommunikationserfah- rung von Hausärzt:innen durch die Nutzung einer Messenger-App in der COVID-19-Pan- demie. DEGAM, 55. Kongress für Allgemeinmedizin und Familienmedizin, Digitalisierung- Chancen und Risiken für die Allgemeinmedizin, Lübeck. 16.09.2021.
Müller, A., Nohl-Deryk, P., Schulz-Rothe, S., Elliott, P., Thielmann, A., Müller, B., Guethlin,
C. & Gerlach, F. (2021). Usability of a communication tool used by general practitioners and public health workers during the COVID-19 pandemic: a proof-of-concept-study. 92nd EGPRN Meeting, Closing evidence gaps in general practice/family medicine, Online. 30.04.2021.
Nohl-Deryk, P., Güthlin, C., Kurtz, P., & Müller, A. (2021). Usage of a secure instant mes- saging tool for exchange of information about Covid-19 between general practitioners and local health authorities. Doc21dkvf047. https://doi.org/10.3205/21dkvf047
Nohl-Deryk, P., Güthlin, C. & Müller, A. (2021). Wofür nutzten Hausärzt:innen Apps in der Covid-19 Pandemie? DEGAM, 55. Kongress für Allgemeinmedizin und Familienmedizin, Digitalisierung- Chancen und Risiken für die Allgemeinmedizin, Lübeck. 16.09.2021.
Panchyrz, I., Pohl, S., Hoffmann, J., Gatermann, C., Walther, F., Harst, L., Held, H.-C., Kleber, C., Albrecht, M., & Schmitt, J. (2021). The role of university hospitals in regional health care management for coping with the COVID-19 pandemic. Zeitschrift Für Evidenz, Fort- bildung Und Qualität Im Gesundheitswesen, 167, 68–77. https://doi.org/10.1016/j.zefq.2021.09.004
Pohl, S., Panchyrz, I., Hoffmann, J., Gatermann, C., Harst, L., Walther, F., Held, H.-C., Kleber, C., Albrecht, M., & Schmitt, J. (2021). Consensus on best practices in regional inpatient pandemic management at German university hospitals using a mixed-method approach. Doc21dkvf264. https://doi.org/10.3205/21dkvf264
Polotzek, K., Karch, A., Karschau, J., von Wagner, M., Lünsmann, B., Menk, M., Römmele, C., & Schmitt, J. (2021). COVID-19-Pandemie: Regionale Steuerung der Patienten. Dtsch Arztebl International, 118(3), 84-.
Priesemann, V., Brinkmann, M.M., Ciesek, S., Cuschieri, S., Czypionka, T., Giordano, G., Gurdasani, D., Hanson, C., Hens, N., Iftekhar, E., Kelly-Irving, M., Klimek, P., Kretzschmar, M., Peichl, A., Perc, M., Sannino, F., Schernhammer, E., Schmidt, A., Staines, A., Szczurek, E. (2021), Calling for pan-European commitment for rapid and sustained reduction in SARS- CoV-2 infections. Lancet. 2021; Jan 9;397(10269):92-93. doi: 10.1016/S0140- 6736(20)32625-8
Priesemann, V., Balling, R., Brinkemann, M.M., Ciesek, S., Czypionka, T., Eckerle, I., Giordano, G., Hanson, C., Hel, Z., Hotulainen, P., Klimek, P., Nassehi, A., Peichl, A., Perc, M., Petelos, E., Prainsack, B., Szczurek, E. (2021), An action plan for pan-European defence against new SARS-CoV-2 variants, Lancet, 2021 Feb 6;397(10273):469-470, doi: 10.1016/S0140-6736(21)00150-1
Priesemann, V., Brinkmann, M.M., Ciesek, S., Cuschieri, S., Czypionka, T., Giordano, G., Hanson, C., Hens, N., Iftekhar, E., Klimek, P, Kretzschmar, M., Peichl, A., Perc, M., Sannino, F., Schernhammer, E., Schmidt, A., Staines, A., Szczurek, E., (2021), Call for a pan-European COVID-19 response must be comprehensive – Authors‘ reply, Lancet, 2021, Apr 24;397(10284): 1541. doi: 10.1016/S0140-6736(21)00462-1.
Revet A, Hebebrand J, Anagnostopoulos D, Kehoe LA, Gradl-Dietsch G; COVID-19 Child and Adolescent Psychiatry Consortium (Bender-S), Klauser P. Perceived impact of the COVID-19 pandemic on child and adolescent psychiatric services after 1 year (Febru- ary/March 2021): ESCAP CovCAP survey. Eur Child Adolesc Psychiatry. 2021 Jul 29:1-8. doi: 10.1007/s00787-021-01851-1. Online ahead of print.
Revet A, Hebebrand J, Anagnostopoulos D, Kehoe LA; COVID-19 Child and Adolescent Psychiatry Consortium (Bender-S), Klauser P. ESCAP CovCAP survey of heads of academic departments to assess the perceived initial (April/May 2020) impact of the COVID-19 pandemic on child and adolescent psychiatry services. Eur Child Adolesc Psychiatry. 2021 Jan 20:1-10. doi: 10.1007/s00787-020-01699-x. Online ahead of print.
Roessler, M., Tesch, F., Batram, M., Jacob, J., Loser, F., Weidinger, O., Wende, D., Vivirito, A., Toepfner, N., Seifert, M., Nagel, O., König, C., Jucknewitz, R., Armann, J. P., Berner, R., Treskova-Schwarzbach, M., Hertle, D., Scholz, S., Stern, S., … Schmitt, J. (2021). Post COVID-19 in children, adolescents, and adults: Results of a matched cohort study includ- ing more than 150,000 individuals with COVID-19 (S. 2021.10.21.21265133). https://doi.org/10.1101/2021.10.21.21265133
Rößler, M., Jacob, J., Risch, L., Tesch, F., Enders, D., Wende, D., Jucknewitz, R., Weidinger, O., Batram, M., Ballesteros, P., Baßler, S., Hertle, D., Repschläger, U., Richter, N., Schulte, C., Schramm, A., Sobik, F., Treskova-Schwarzbach, M., Scholz, S., … Walker, J. (2021). Hierar- chisierung von Risikofaktoren für schwere COVID-19-Erkrankungsverläufe im Kontext der COVID-19-Schutzimpfungen. https://doi.org/10.25646/8405.2
Röthke, N., Wollschläger, D., Kunzler, A. M., Rohde, A., Molter, S., Bodenstein, M., Reif, A., Walter, H., Lieb, K., & Tüscher, O. (2021). Psychische Belastung, Resilienz und Absentis- musneigung bei Gesundheitspersonal in Deutschland während der ersten COVID-19- Pandemiewelle im Frühjahr 2020. Der Nervenarzt, 92(6), 579–590. https://doi.org/10.1007/s00115-021-01132-x
Schmidt, M., Kugai, S., Amarell, N., & Weltermann, B. (2021). Handlungsfähigkeit von Hausärzt*innen während der COVID-19-Pandemie. DocV-15-05. https://doi.org/10.3205/21degam086
Schmidt, M., Löwe, C., Kugai, S., Thielmann, A., & Weltermann, B. (2021). Kommunikati- ons- und Kooperationsstrukturen von Hausärzt*innen und Gesundheitsämtern – Erkennt- nisse der egePan-Studie. DocV-22-02. https://doi.org/10.3205/21degam120.
Schmitt, J., Harst, L., Weber, T.O., Sedlmayr, M., Ciesek, S., Apfelbacher, C., Bajbouj, M., Bier- baum, V., Combs, S., Drosten, C., Geraedts, M., Haier, J., Ihle, P., Lieb, K., Rohde, G., Schmid- berger, H., Vogelmeier, C., Weber-Carstens, S., Weltermann, B., von Wagner, M. (2020). Konzept für ein bundesweites Pandemiemanagement im Rahmen des Netzwerks Univer- sitätsmedizin. German Medical Science GMS Publishing House. 10.3205/20dkvf053.
Schug C, Erim Y, Geiser F, Hiebel N, Beschoner P, Jerg-Bretzke L, Albus C, Weidner K, Steudte-Schmiedgen S, Borho A, Lieb M, Morawa E. [Vaccination willingness against COVID-19 among healthcare workers in Germany : Results from a University Medicine Net- work survey between November 2020 and January 2021]. Bundesgesundheitsblatt Ge- sundheitsforschung Gesundheitsschutz. 2022 Jan;65(1):74-85. Online verfügbar unter: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8458789/pdf/103_2021_Article_3418.pdf
Schug C, Geiser F, Hiebel N, Beschoner P, Jerg-Bretzke L, Albus C, Weidner K, Morawa E, Erim Y. Sick Leave and Intention to Quit the Job among Nursing Staff in German Hospitals during the COVID-19 Pandemic. Int J Environ Res Public Health. 2022 Feb 10;19(4):1947. Online verfügbar unter: https://www.ncbi.nlm.nih.gov/pmc/arti- cles/PMC8872054/pdf/ijerph-19-01947.pdf
Schug, C., Morawa, E., Geiser, F., Hiebel, N., Beschoner, P., Jerg-Bretzke, L., Albus, C., Weid- ner, K., Steudte-Schmiedgen, S., Borho, A., Lieb, M., & Erim, Y. (2021). Social Support and Optimism as Protective Factors for Mental Health among 7765 Healthcare Workers in Ger- many during the COVID-19 Pandemic: Results of the VOICE Study. International Journal of Environmental Research and Public Health, 18(7), 3827. Online verfügbar unter: doi.org/10.3390/ijerph18073827
Schmuck, J., Hiebel, N., Rabe, M., Schneider, J., Erim, Y., Morawa, E., Jerg-Bretzke, L., Be- schoner, P., Albus, C., Hannemann, J., Weidner, K., Steudte-Schmiedgen, S., Radbruch, L., Brunsch, H., & Geiser, F. (2021). Sense of coherence, social support and religiosity as re- sources for medical personnel during the COVID-19 pandemic: A web-based survey among 4324 health care workers within the German Network University Medicine. PLOS ONE, 16(7), e0255211. https://doi.org/10.1371/journal.pone.0255211
Schneider, J. N., Hiebel, N., Kriegsmann-Rabe, M., Schmuck, J., Erim, Y., Morawa, E., Jerg- Bretzke, L., Beschoner, P., Albus, C., Hannemann, J., Weidner, K., Steudte-Schmiedgen, S., Radbruch, L., Brunsch, H., & Geiser, F. (2021). Moral Distress in Hospitals During the First Wave of the COVID-19 Pandemic: A Web-Based Survey Among 3,293 Healthcare Work- ers Within the German Network University Medicine. Frontiers in Psychology, 12, 5295. https://doi.org/10.3389/fpsyg.2021.775204
Schug, C., Morawa, E., Geiser, F., Hiebel, N., Beschoner, P., Jerg-Bretzke, L., Albus, C., Weidner, K., Steudte-Schmiedgen, S., Borho, A., Lieb, M., & Erim, Y. (2021). Social Support and Optimism as Protective Factors for Mental Health among 7765 Healthcare Workers in Germany during the COVID-19 Pandemic: Results of the VOICE Study. International Journal of Environmental Research and Public Health, 18(7), 3827. https://doi.org/10.3390/ijerph18073827
Schuppert, A., Polotzek, K., Schmitt, J., Busse, R., Karschau, J., & Karagiannidis, C. (2021). Different spreading dynamics throughout Germany during the second wave of the COVID-19 pandemic: A time series study based on national surveillance data. The Lancet Regional Health - Europe, 6, 100151. https://doi.org/10.1016/j.lanepe.2021.100151
Steudte-Schmiedgen, S., Stieler, L., Erim, Y., Morawa, E., Geiser, F., Beschoner, P., Jerg- Bretzke, L., Albus, C., Hiebel, N., & Weidner, K. (2021). Correlates and Predictors of PTSD Symptoms Among Healthcare Workers During the COVID-19 Pandemic: Results of the egePan-VOICE Study. Frontiers in Psychiatry, 12, 959. https://doi.org/10.3389/fpsyt.2021.686667
Tomori, D. V., Rübsamen, N., Berger, T., Scholz, S., Walde, J., Wittenberg, I., Lange, B., Kuhlmann, A., Horn, J., Mikolajczyk, R., Jaeger, V. K., & Karch, A. (2021). Individual social contact data and population mobility data as early markers of SARS-CoV-2 transmission dynamics during the first wave in Germany-an analysis based on the COVIMOD study. BMC Medicine, 19(1), 271. https://doi.org/10.1186/s12916-021-02139-6
Veer, I. M., Riepenhausen, A., Zerban, M., Wackerhagen, C., Puhlmann, L. M. C., Engen, H., Köber, G., Bögemann, S. A., Weermeijer, J., Uściłko, A., Mor, N., Marciniak, M. A., As- kelund, A. D., Al-Kamel, A., Ayash, S., Barsuola, G., Bartkute-Norkuniene, V., Battaglia, S., Bobko, Y., … Kalisch, R. (2021). Psycho-social factors associated with mental resilience in the Corona lockdown. Translational Psychiatry, 11(1), 1–11. https://doi.org/10.1038/s41398-020-01150-4
Wenzel, M., Chun, F. K. H., Hinz, O., & Abdel-Karim, B. (2020). Möglichkeiten einer auto- matisierten Auswertung der Thorax-Röntgenaufnahme durch künstliche Intelligenz für Klinik und Praxis. Der Pneumologe, 17(1), 59–64. https://doi.org/10.1007/s10405-019-00297-2
Wurzer, D., Spielhagen, P., Siegmann, A., Gercekcioglu, A., Gorgass, J., Henze, S., Kolar, Y., Koneberg, F., Kukkonen, S., McGowan, H., Schmid-Eisinger, S., Steger, A., Dommasch, M., Haase, H. U., Müller, A., Martens, E., Haller, B., Huster, K. M., & Schmidt, G. (2021). Remote monitoring of COVID-19 positive high-risk patients in domestic isolation: A feasibility study. PLOS ONE, 16(9), e0257095. https://doi.org/10.1371/journal.pone.0257095

MethodCov

Hoven H, Dragano N, Angerer P, Apfelbacher C, Backhaus I, Hoffmann B, Icks A, Wilm S, Fangerau F, Söhner F (2022) Striving for health equality: The importance of social determinants of health and ethical considerations in pandemic preparedness planning. International Journal of Public Health. International Journal of Public Health 67:1604542. doi: 10.3389/ijph.2022.1604542.
Dragano N, Reuter M, Peters A, Engels M, Schmidt B, Greiser KH, Bohn B, Riedel-Heller S, Karch A, Mikolajczyk R, Krause G, Lang O, Panreck L, Rietschel M, Brenner H, Fischer B, Franzke CW, Gastell S, Holleczek B, Jöckel KH, Kaaks R, Keil T, Kluttig A, Kuß O, Legath N, Leitzmann M, Lieb W, Meinke-Franze C, Michels KB, Obi N, Pischon T, Feinkohl I, Rospleszcz S, Schikowski T, Schulze MB, Stang A, Völzke H, Willlich SN, Wirkner K, Zeeb H, Ahrens W, Berger K (2022) Increase in mental disorders during the COVID-19 pandemic - the role of occupational and financial
strains. An analysis of the German National Cohort (NAKO) Study. Deutsches Ärzteblatt International 119: 179–87. DOI: 10.3238/arztebl.m2022.0133.
Backhaus I, Hermsen D, Timm J, Boege F, Lübke N, Degode T, Göbels K, Dragano N (2022) SARS-CoV-2 seroprevalence and determinants of infection in young adults: A population-based seroepidemiological study. Public Health. doi:https://doi.org/10.1016/j.puhe.2022.03.009 (mit NUM-Förderung).
Backhaus I, Hermsen D, Timm J, Boege F, Lübke N, Göbels K, von der Lieth D, Dragano N (2021) Under-ascertainment of COVID-19 cases among first responders: a seroepidemiological study. Occupational Medicine: kqab164. doi.org/10.1093/occmed/kqab164.
Backhaus I, Dragano N (2021) Seroprävalenz COVID-19 Düsseldorf: SERODUS I & II. Feldbericht und vorläufiger Ergebnisbericht. https://www.uniklinik-duesseldorf.de/fileadmin/Fuer-Patientenund-Besucher/Kliniken-ZentrenInstitute/Institute/Institut_fuer_Medizinische_Soziologie/Forschung/SeroDus/Feld-_und_Ergebnisbericht_SERODUS-I_SERODUS-II_03-02-2021_v01.pdf
Dragano N, Hoebel J, Wachtler B, Diercke M, Lunau T, Wahrendorf M (2021). Soziale Ungleichheit in der regionalen Ausbreitung von SARS-CoV-2. Bundesgesundheitsblatt- Gesundheitsforschung - Gesundheitsschutz, 64:1116-1124. https://doi.org/10.1007/s00103-021-03387-w.

NAPKON

Anton, G., Kuehn-Steven, A., Taucher, M.K., Bernemann, I, Illig, T. Quality management in times of COVID-19: Remote audits as tool to assess sample quality for NAPKON. European Biobank Week 2021.
Antoniou KM, Vasarmidi E, Russell AM, Andrejak C, Crestani B, Delcroix M, Dinh-Xuan AT, Poletti V, Sverzellati N, Vitacca M, Witzenrath M, Tonia T, Spanevello A. European Respiratory Society statement on long COVID follow-up. Eur Respir J. 2022 Aug 4;60(2):2102174. doi: 10.1183/13993003.02174-2021. PMID: 35144991.
Bernardes JP, Mishra N, Tran F, Bahmer T, Best L, Blase JI, Bordoni D, Franzenburg J, Geisen U, Josephs-Spaulding J, Köhler P, Künstner A, Rosati E, Aschenbrenner AC, Bacher P, Baran N, Boysen T, Brandt B, Bruse N, Dörr J, Dräger A, Elke G, Ellinghaus D, Fischer J, Forster M, Franke A, Franzenburg S, Frey N, Friedrichs A, Fuß J, Glück A, Hamm J, Hinrichsen F, Hoeppner MP, Imm S, Junker R, Kaiser S, Kan YH, Knoll R, Lange C, Laue G, Lier C, Lindner M, Marinos G, Markewitz R, Nattermann J, Noth R, Pickkers P, Rabe KF, Renz A, Röcken C, Rupp J, Schaffarzyk A, Scheffold A, Schulte-Schrepping J, Schunk D, Skowasch D, Ulas T, Wandinger KP, Wittig M, Zimmermann J, Busch H, Hoyer BF, Kaleta C, Heyckendorf J, Kox M, Rybniker J, Schreiber S, Schultze JL, Rosenstiel P; HCA Lung Biological Network; Deutsche COVID-19 Omics Initiative (DeCOI). Longitudinal Multi-omics Analyses Identify Responses of Megakaryocytes, Erythroid Cells, and Plasmablasts as Hallmarks of Severe COVID-19. Immunity. 2020 Dec 15;53(6):1296-1314.e9. doi: 10.1016/j.immuni.2020.11.017. Epub 2020 Nov 26. IF 31.745.
Dannebaum R, Suwalski P, Asgharian H, Du Zhipei G, Lin H, Weiner J, Holtgrewe M, Thibeault C, Müller M, Wang X, Karadeniz Z, Saccomanno J, Doehn JM, Hübner RH, Hinzmann B, Blüher A, Siemann S, Telman D, Suttorp N, Witzenrath M, Hippenstiel S, Skurk C, Poller W, Sander LE, Beule D, Kurth F, Guettouche T, Landmesser U, Berka J, Luong K; Pa-COVID Study Group; Rubelt F, Heidecker B. Highly multiplexed immune repertoire sequencing links multiple lymphocyte classes with severity of response to COVID-19. EClinicalMedicine. 2022 Jun;48:101438. doi: 10.1016/j.eclinm.2022.101438. Epub 2022 May 14. PMID: 35600330.
Demichev V, Tober-Lau P, Lemke O, Nazarenko T, Thibeault C, Whitwell H, Röhl A, Freiwald A, Szyrwiel L, Ludwig D, Correia-Melo C, Aulakh SK, Helbig ET, Stubbemann P, Lippert LJ, Grüning NM, Blyuss O, Vernardis S, White M, Messner CB, Joannidis M, Sonnweber T, Klein SJ, Pizzini A, Wohlfarter Y, Sahanic S, Hilbe R, Schaefer B, Wagner S, Mittermaier M, Machleidt F, Garcia C, Ruwwe-Glösenkamp C, Lingscheid T, Bosquillon de Jarcy L, Stegemann MS, Pfeiffer M, Jürgens L, Denker S, Zickler D, Enghard P, Zelezniak A, Campbell A, Hayward C, Porteous DJ, Marioni RE, Uhrig A, Müller-Redetzky H, Zoller H, Löffler-Ragg J, Keller MA, Tancevski I, Timms JF, Zaikin A, Hippenstiel S, Ramharter M, Witzenrath M, Suttorp N, Lilley K, Mülleder M, Sander LE; PA-COVID-19 Study group, Ralser M, Kurth F. A time-resolved proteomic and prognostic map of COVID-19. Cell Syst. 2021; 12(8):780-794.e7. doi: 10.1016/j.cels.2021.05.005. IF 10.304 (2020).
Doehn JM, Tabeling C, Biesen R, Saccomanno J, Madlung E, Pappe E, Gabriel F, Kurth F, Meisel C, Corman VM, Hanitsch LG, Treskatsch S, Heim K, Stegemann MS, Ruwwe-Glösenkamp C, Müller-Redetzky HC, Uhrig A, Somasundaram R, Spies C, von Bernuth H, Hofmann J, Drosten C, Suttorp N, Witzenrath M, Sander LE, Hübner RH. CD169/SIGLEC1 is expressed on circulating monocytes in COVID-19 and expression levels are associated with disease severity. Infection. 2021; 49(4):757-762. doi: 10.1007/s15010-021-01606-9. IF 3.553 (2020).
Hadzibegovic S, Lena A, Churchill TW, Ho JE, Potthoff S, Denecke C, Rösnick L, Heim KM, Kleinschmidt M, Sander LE, Witzenrath M, Suttorp N, Krannich A, Porthun J, Friede T, Butler J, Wilkenshoff U, Pieske B, Landmesser U, Anker SD, Lewis GD, Tschöpe C, Anker MS. Heart failure with preserved ejection fraction according to the HFA-PEFF score in COVID-19 patients: clinical correlates and echocardiographic findings. Eur J Heart Fail. 2021 Nov;23(11):1891-1902. doi: 10.1002/ejhf.2210. Epub 2021 Jul 12. PMID: 33932255.
Hopff S M, Tilch K, Kraus M, Lorenz-Depiereux L, Anton G, Appel K, Bahmer T, Bartschke A, Bellinghausen C, Bernemann I, Brechtel M, Brünn C, Fiessler C, Geisler R, Hansch S, Hanses F, Hanß S, Heyder R, Hoffmann A-L, Horn A, Jakob C, Jiru-Hillmann S, Keil T, Khodamoradi Y, Kohls M, Krefting D, Kunze S, Kurth F, Lieb W, Lippert L, Lorbeer R, Lysyakova L, Maetzler C, Miljukov O, Nauck M, Pilgram L, Püntmann V, Reese J-P, Reinke L, Rudolph S, Sass J, Schäfer C, Schaller J, Schattschneider M, Scheer C, Scherer M, Schmidt J, Schmidt S, Schons M, Seibel K, Stahl D, Stecher M, Steinbeis F, Störk St, Tauchert M, Thibeault C, Töpfner N, Ungethüm K, Valentin H, Wiedmann S, Zoller T, Berner R, Krawczak M, Nagel E, Illig T, Schreiber S, Witzenrath M, Heuschmann P, Vehreschild J J. Ethical and coordinative challenges in setting up a national cohort study exemplified by the German National Pandemic Cohort Network (NAPKON), Abstract Kongress ECCMID 2022.
Horn A, Krist L, Lieb W, Montellano FA, Kohls M, Haas K, Gelbrich G, Bolay-Gehrig SJ, Morbach C, Reese JP, Störk S, Fricke J, Zoller T, Schmidt S, Triller P, Kretzler L, Rönnefarth M, Von Kalle C, Willich SN, Kurth F, Steinbeis F, Witzenrath M, Bahmer T, Hermes A, Krawczak M, Reinke L, Maetzler C, Franzenburg J, Enderle J, Flinspach A, Vehreschild J, Schons M, Illig T, Anton G, Ungethüm K, Finkenberg BC, Gehrig MT, Savaskan N, Heuschmann PU, Keil T, Schreiber S.: ILong-term health sequelae and quality of life at least 6 months after infection with SARS-CoV-2: design and rationale of the COVIDOM-study as part of the NAPKON population-based cohort platform (POP). Infection. 2021 Dec;49(6):1277-1287. doi: 10.1007/s15010-021-01707-5. Epub 2021 Oct 12.PMID: 34642875. IF: 3.553 (2021)
Hönzke K, Obermayer B, Mache C, Fathykova D, Kessler M, Dökel S, Wyler E, Baumgardt M, Löwa A, Hoffmann K, Graff P, Schulze J, Mieth M, Hellwig K, Demir Z, Biere B, Brunotte L, Mecate-Zambrano A, Bushe J, Dohmen M, Hinze C, Elezkurtaj S, Tönnies M, Bauer TT, Eggeling S, Tran HL, Schneider P, Neudecker J, Rückert JC, Schmidt-Ott KM, Busch J, Klauschen F, Horst D, Radbruch H, Radke J, Heppner F, Corman VM, Niemeyer D, Müller MA, Goffinet C, Mothes R, Pascual-Reguant A, Hauser AE, Beule D, Landthaler M, Ludwig S, Suttorp N, Witzenrath M, Gruber AD, Drosten C, Sander LE, Wolff T, Hippenstiel S, Hocke AC. Human lungs show limited permissiveness for SARS-CoV-2 due to scarce ACE2 levels but virus-induced expansion of inflammatory macrophages. Eur Respir J. 2022 Dec 1;60(6):2102725. doi: 10.1183/13993003.02725-2021. PMID: 35728978.
Lingscheid T, Lippert LJ, Hillus D, Kruis T, Thibeault C, Helbig ET, Tober-Lau P, Pfäfflin F, Müller-Redetzky H, Witzenrath M, Zoller T, Uhrig A, Opitz B, Suttorp N, Kramer TS, Sander LE, Stegemann MS, Kurth F. Characterization of antimicrobial use and co-infections among hospitalized patients with COVID-19: a prospective observational cohort study. Infection. 2022 Dec;50(6):1441-1452. doi: 10.1007/s15010-022-01796-w. Epub 2022 Apr 14. PMID: 35420370.
Koll CEM, Hopff SM, Meurers T, Lee CH, Kohls M, Stellbrink C, Thibeault C, Reinke L, Steinbrecher S, Schreiber S, Mitrov L, Frank S, Miljukov O, Erber J, Hellmuth JC, Reese JP, Steinbeis F, Bahmer T, Hagen M, Meybohm P, Hansch S, Vadász I, Krist L, Jiru-Hillmann S, Prasser F, Vehreschild JJ; NAPKON Study Group. Statistical biases due to anonymization evaluated in an open clinical dataset from COVID-19 patients. Sci Data. 2022 Dec 21;9(1):776. doi: 10.1038/s41597-022-01669-9. PMID: 36543828.
Kühnapfel A, Horn K, Klotz U, Kiehntopf M, Rosolowski M, Loeffler M, Ahnert P, Suttorp N, Witzenrath M, Scholz M. Genetic Regulation of Cytokine Response in Patients with Acute Community-Acquired Pneumonia. Genes (Basel). 2022 Jan 6;13(1):111. doi: 10.3390/genes13010111. PMID: 35052452; PMCID: PMC8774373.Mühlemann B, Thibeault C, Hillus D, Helbig ET, Lippert LJ, Tober-Lau P, Schwarz T, Müller MA; Pa-COVID-19 collaborative study group; Witzenrath M, Suttorp N, Sander LE, Drosten C, Jones TC, Corman VM, Kurth F. Impact of dexamethasone on SARS-CoV-2 concentration kinetics and antibody response in hospitalized COVID-19 patients: results from a prospective observational study. Clin Microbiol Infect. 2021 Oct;27(10):1520.e7-1520.e10. doi: 10.1016/j.cmi.2021.06.008. Epub 2021 Jun 15. PMID: 34139335.
Michalick L, Weidenfeld S, Grimmer B, Fatykhova D, Solymosi PD, Behrens F, Dohmen M, Brack MC, Schulz S, Thomasch E, Simmons S, Müller-Redetzky H, Suttorp N, Kurth F, Neudecker J, Toennies M, Bauer TT, Eggeling S, Corman VM, Hocke AC, Witzenrath M, Hippenstiel S, Kuebler WM. Plasma mediators in patients with severe COVID-19 cause lung endothelial barrier failure. Eur Respir J. 2021 Mar 11;57(3):2002384. doi: 10.1183/13993003.02384-2020. PMID: 33154030.
Mühlemann B, Thibeault C, Hillus D, Helbig ET, Lippert LJ, Tober-Lau P, Schwarz T, Müller MA; Pa-COVID-19 collaborative study group, Witzenrath M, Suttorp N, Sander LE, Drosten C, Jones TC, Corman VM, Kurth F. Impact of dexamethasone on SARS-CoV-2 concentration kinetics and antibody response in hospitalized COVID-19 patients: results from a prospective observational study. Clin Microbiol Infect. 2021; Jun 15:S1198-743X(21)00327-X. doi: 10.1016/j.cmi.2021.06.008. IF 8.067 (2020).
Nouailles G, Wyler E, Pennitz P, Postmus D, Vladimirova D, Kazmierski J, Pott F, Dietert K, Muelleder M, Farztdinov V, Obermayer B, Wienhold SM, Andreotti S, Hoefler T, Sawitzki B, Drosten C, Sander LE, Suttorp N, Ralser M, Beule D, Gruber AD, Goffinet C, Landthaler M, Trimpert J, Witzenrath M. Temporal omics analysis in Syrian hamsters unravel cellular effector responses to moderate COVID-19. Nat Commun. 2021; 12(1):4869. doi: 10.1038/s41467-021-25030-7. IF 14.919 (2020).
Sass, J, Bartschke, A, Lehne, M, Essenwanger, A, Rinaldi, E, Rudolph, S, Heitmann, K, Vehreschild, J, von Kalle, C, Thun, S. The German Corona Consensus Dataset (GECCO): a standardized dataset for COVID-19 research in university medicine and beyond. BMC Med Inform Decis Mak 20, 341 (2020). doi.org/10.1186/s12911-020-01374-w. IF 2.796.
Schlickeiser S, Schwarz T, Steiner S, Wittke K, Al Besher N, Meyer O, Kalus U, Pruß A, Kurth F, Zoller T, Witzenrath M, Sander LE, Müller MA, Scheibenbogen C, Volk HD, Drosten C, Corman VM, Hanitsch LG. Disease Severity, Fever, Age, and Sex Correlate With SARS-CoV-2 Neutralizing Antibody Responses. Front Immunol. 2021 Jan 29;11:628971. doi: 10.3389/fimmu.2020.628971. PMID: 33584731.
Steinbeis F, Thibeault C, Doellinger F, Ring RM, Mittermaier M, Ruwwe-Glösenkamp C, Alius F, Knape P, Meyer HJ, Lippert LJ, Helbig ET, Grund D, Temmesfeld-Wollbrück B, Suttorp N, Sander LE, Kurth F, Penzkofer T, Witzenrath M, Zoller T. Severity of respiratory failure and computed chest tomography in acute COVID-19 correlates with pulmonary function and respiratory symptoms after infection with SARS-CoV-2: An observational longitudinal study over 12 months. Respir Med. 2021 Dec 1;191:106709. doi: 10.1016/j.rmed.2021.106709.
Steinbeis F, Knape P, Mittermaier M, Helbig ET, Tober-Lau P, Thibeault C, Lippert LJ, Xiang W, Müller-Plathe M, Steinbrecher S, Meyer HJ, Ring RM, Ruwwe-Glösenkamp C, Alius F, Li Y, Müller-Redetzky H, Uhrig A, Lingscheid T, Grund D, Temmesfeld-Wollbrück B, Suttorp N, Sander LE, Kurth F, Witzenrath M, Zoller T. Functional limitations 12 months after SARS-CoV-2 infection correlate with initial disease severity: An observational study of cardiopulmonary exercise capacity testing in COVID-19 convalescents. Respir Med. 2022 Oct;202:106968. doi: 10.1016/j.rmed.2022.106968. Epub 2022 Aug 28. PMID: 36081267.
Tanacli R, Doeblin P, Götze C, Zieschang V, Faragli A, Stehning C, Korosoglou G, Erley J, Weiss J, Berger A, Pröpper F, Steinbeis F, Kühne T, Seidel F, Geisel D, Cannon Walter-Rittel T, Stawowy P, Witzenrath M, Klingel K, Van Linthout S, Pieske B, Tschöpe C, Kelle S. COVID-19 vs. Classical Myocarditis Associated Myocardial Injury Evaluated by Cardiac Magnetic Resonance and Endomyocardial Biopsy. Front Cardiovasc Med. 2021 Dec 24;8:737257. doi: 10.3389/fcvm.2021.737257. PMID: 35004872.
Tauchert M, Bernemann I, Kühn-Steven A, Kopfnagel V, Kunze S, Illig T, Anton G. Digital knowledge management within the NAPKON study. Abstract. 11. Nationales Biobanken Symposium. 2022.
Thibeault C, Mühlemann B, Helbig ET, Mittermaier M, Lingscheid T, Tober-Lau P, Meyer-Arndt LA, Meiners L, Stubbemann P, Haenel SS, Bosquillon de Jarcy L, Lippert L, Pfeiffer M, Stegemann MS, Roehle R, Wiebach J, Hippenstiel S, Zoller T, Müller-Redetzky H, Uhrig A, Balzer F, von Kalle C, Suttorp N, Jones TC, Drosten C, Witzenrath M, Sander LE; Pa-COVID Study Group, Corman VM, Kurth F. Clinical and virological characteristics of hospitalised COVID-19 patients in a German tertiary care centre during the first wave of the SARS-CoV-2 pandemic: a prospective observational study. Infection. 2021; 49(4):703-714. doi: 10.1007/s15010-021-01594-w. IF 3.553 (2020).
Thun, S, Bartschke, A, Sass, J, von Kalle, C, Essenwanger, A, Rudolph, S. GECCO: Einigung Auf Datensatz Für COVID-19-Forschung. EHEALTHCOM 2020; 5:14-17. https://e-health-com.de/fileadmin/user_upload/dateien/ePaper/EHC_5_2020_ePaper.pdf.
Thun, S, Sass, J, Bartschke, A 2021. German Corona Consensus Datensatz (GECCO): Verbesserter Austausch von COVID-19-Forschungsdaten. kma - Klinik Management aktuell 2021; 26(06): 55-56. DOI: 10.1055/s-0041-1731187.
Wang Z, Cryar A, Lemke O, Tober-Lau P, Ludwig D, Helbig ET, Hippenstiel S, Sander LE, Blake D, Lane CS, Sayers RL, Mueller C, Zeiser J, Townsend S, Demichev V, Mülleder M, Kurth F, Sirka E, Hartl J, Ralser M. A multiplex protein panel assay for severity prediction and outcome prognosis in patients with COVID-19: An observational multi-cohort study. EClinicalMedicine. 2022 Jul;49:101495. doi: 10.1016/j.eclinm.2022.101495. Epub 2022 Jun 9. PMID: 35702332.
Wendisch D, Dietrich O, Mari T, von Stillfried S, Ibarra IL, Mittermaier M, Mache C, Chua RL, Knoll R, Timm S, Brumhard S, Krammer T, Zauber H, Hiller AL, Pascual-Reguant A, Mothes R, Bülow RD, Schulze J, Leipold AM, Djudjaj S, Erhard F, Geffers R, Pott F, Kazmierski J, Radke J, Pergantis P, Baßler K, Conrad C, Aschenbrenner AC, Sawitzki B, Landthaler M, Wyler E, Horst D; Deutsche COVID-19 OMICS Initiative (DeCOI), Hippenstiel S, Hocke A, Heppner FL, Uhrig A, Garcia C, Machleidt F, Herold S, Elezkurtaj S, Thibeault C, Witzenrath M, Cochain C, Suttorp N, Drosten C, Goffinet C, Kurth F, Schultze JL, Radbruch H, Ochs M, Eils R, Müller-Redetzky H, Hauser AE, Luecken MD, Theis FJ, Conrad C, Wolff T, Boor P, Selbach M, Saliba AE, Sander LE. SARS-CoV-2 infection triggers profibrotic macrophage responses and lung fibrosis. Cell. 2021 Dec 22;184(26):6243-6261.e27. doi: 10.1016/j.cell.2021.11.033.
Weiner J, Suwalski P, Holtgrewe M, Rakitko A, Thibeault C, Müller M, Patriki D, Quedenau C, Krüger U, Ilinsky V, Popov I, Balnis J, Jaitovich A, Helbig ET, Lippert LJ, Stubbemann P, Real LM, Macías J, Pineda JA, Fernandez-Fuertes M, Wang X, Karadeniz Z, Saccomanno J, Doehn JM, Hübner RH, Hinzmann B, Salvo M, Blueher A, Siemann S, Jurisic S, Beer JH, Rutishauser J, Wiggli B, Schmid H, Danninger K, Binder R, Corman VM, Mühlemann B, Arjun Arkal R, Fragiadakis GK, Mick E, Comet C, Calfee CS, Erle DJ, Hendrickson CM, Kangelaris KN, Krummel MF, Woodruff PG, Langelier CR, Venkataramani U, García F, Zyla J, Drosten C, Alice B, Jones TC, Suttorp N, Witzenrath M, Hippenstiel S, Zemojtel T, Skurk C, Wolfgang P, Borodina T, Pa-Covid SG, Ripke S, Sander LE, Beule D, Landmesser U, Guettouche T, Kurth F, Heidecker B.Increased risk of severe clinical course of COVID-19 in carriers of HLA-C*04:01. EClinicalMedicine. 2021; Sep 2:101099. doi: 10.1016/j.eclinm.2021.101099.
Winkelmann S, Korth A, Voss B, Nasr MA, Behrend N, Pudszuhn A, Hofmann VM, Schendzielorz P, Maetzler C, Hermes A, Borzikowsky C, Bahmer T, Lieb W, Schreiber S, Störk S, Montellano FA, Witzenrath M, Keil T, Krawczak M, Laudien M, Napkon Study Group OBOT. Persisting chemosensory dysfunction in COVID-19 - a cross-sectional population-based survey. Rhinology. 2022 Oct 27. doi: 10.4193/Rhin22.176. Epub ahead of print. PMID: 36323438.
Witzenrath M, Kuebler WM. The CypA-netics of Ventilator-induced Lung Injury. Am J Respir Crit Care Med. 2021; 204(4):385-387. doi: 10.1164/rccm.202104-0919ED. IF 21.405 (2020).
Wygrecka M, Birnhuber A, Seeliger B, Michalick L, Pak O, Schultz AS, Schramm F, Zacharias M, Gorkiewicz G, David S, Welte T, Schmidt JJ, Weissmann N, Schermuly RT, Barreto G, Schaefer L, Markart P, Brack MC, Hippenstiel S, Kurth F, Sander LE, Witzenrath M, Kuebler WM, Kwapiszewska G, Preissner KT. Altered fibrin clot structure and dysregulated fibrinolysis contribute to thrombosis risk in severe COVID-19. Blood Adv. 2022 Feb 8;6(3):1074-1087. doi: 10.1182/bloodadvances.2021004816. PMID: 34861681.
Wyler E, Adler JM, Eschke K, Teixeira Alves G, Peidli S, Pott F, Kazmierski J, Michalick L, Kershaw O, Bushe J, Andreotti S, Pennitz P, Abdelgawad A, Postmus D, Goffinet C, Kreye J, Reincke SM, Prüss H, Blüthgen N, Gruber AD, Kuebler WM, Witzenrath M, Landthaler M, Nouailles G, Trimpert J. Key benefits of dexamethasone and antibody treatment in COVID-19 hamster models revealed by single-cell transcriptomics. Mol Ther. 2022 May 4;30(5):1952-1965. doi: 10.1016/j.ymthe.2022.03.014. Epub 2022 Mar 24. PMID: 35339689.

Organo-Strat

Adhikary PP, Ul Ain Q, Hocke AC, Hedtrich S. COVID-19 highlights the model dilemma in biomedical research. Nat Rev Mater 2021: 1-3.
Aguilar C, Alves da Silva M, Saraiva M, Neyazi M, Olsson IAS, Bartfeld S. Organoids as host models for infection biology - a review of methods. Exp Mol Med 2021; 53: 1471-1482.
Aschman T, Schneider J, Greuel S, Meinhardt J, Streit S, Goebel HH et al. Association Between SARS-CoV-2 Infection and Immune-Mediated Myopathy in Patients Who Have Died. JAMA Neurol 2021; 78: 948-960.
Brunotte L, Zheng S, Mecate-Zambrano A, Tang J, Ludwig S, Rescher U et al. Combination Therapy with Fluoxetine and the Nucleoside Analog GS-441524 Exerts Synergistic Antiviral Effects against Different SARS-CoV-2 Variants In Vitro. Pharmaceutics 2021; 13.
Deinhardt-Emmer S, Bottcher S, Haring C, Giebeler L, Henke A, Zell R et al. SARS-CoV-2 causes severe epithelial inflammation and barrier dysfunction. J Virol 2021.
Deinhardt-Emmer S, Wittschieber D, Sanft J, Kleemann S, Elschner S, Haupt KF et al. Early postmortem mapping of SARS-CoV-2 RNA in patients with COVID-19 and the correlation with tissue damage. Elife 2021; 10.
Demichev V, Tober-Lau P, Lemke O, Nazarenko T, Thibeault C, Whitwell H et al. A time-resolved proteomic and prognostic map of COVID-19. Cell Syst 2021; 12: 780-+.
Gassen NC, Papies J, Bajaj T, Emanuel J, Dethloff F, Chua RL et al. SARS-CoV-2-mediated dysregulation of metabolism and autophagy uncovers host-targeting antivirals. Nat Commun 2021; 12: 3818.
Georg P, Astaburuaga-García R, Bonaguro L, Brumhard S, Michalick L, Lippert LJ et al. Complement activation induces excessive T cell cytotoxicity in severe COVID-19. Cell 2022; 185: 493-512.e425.
Gruber AD, Firsching TC, Trimpert J, Dietert K. Hamster models of COVID-19 pneumonia reviewed: How human can they be? Vet Pathol 2021.
Gruber AD, Osterrieder N, Bertzbach LD, Vladimirova D, Greuel S, Ihlow J et al. Standardization of Reporting Criteria for Lung Pathology in SARS-CoV-2–infected Hamsters: What Matters? Am. J. Respir. Cell Mol. Biol. 2020; 63: 856-859.
Günl F, Mecate-Zambrano A, Rehländer S, Hinse S, Ludwig S, Brunotte L. Shooting at a Moving Target-Effectiveness and Emerging Challenges for SARS-CoV-2 Vaccine Development. Vaccines (Basel) 2021; 9.
Honzke K. OB, Mache C., Fathykova D., Kessler M., Dokel S., Wyler E. …Gruber A.D., Drosten C., Sander LE., Wolff T., Hippenstiel S., Hocke A.C. Human lungs show limited permissiveness for 1 SARS-CoV-2 due to scarce ACE2 levels but strong virus-induced immune activation in alveolar macrophages. In revision Eur Respir J.
Hönzke K, Obermayer B, Mache C, Fathykova D, Kessler M, Dökel S, Wyler E, Baumgardt M, Löwa A, Hoffmann K, Graff P, Schulze J, Mieth M, Hellwig K, Demir Z, Biere B, Brunotte L, Mecate-Zambrano A, Bushe J, Dohmen M, Hinze C, Elezkurtaj S, Tönnies M, Bauer TT, Eggeling S, Tran HL, Schneider P, Neudecker J, Rückert JC, Schmidt-Ott KM, Busch J, Klauschen F, Horst D, Radbruch H, Radke J, Heppner F, Corman VM, Niemeyer D, Müller MA, Goffinet C, Mothes R, Pascual-Reguant A, Hauser AE, Beule D, Landthaler M, Ludwig S, Suttorp N, Witzenrath M, Gruber AD, Drosten C, Sander LE, Wolff T, Hippenstiel S, Hocke AC. Human lungs show limited permissiveness for SARS-CoV-2 due to scarce ACE2 levels but virus-induced expansion of inflammatory macrophages. Eur Respir J. 2022 Dec 1;60(6):2102725. doi: 10.1183/13993003.02725-2021. PMID: 35728978
Hornung F, Rogal J, Loskill P, Löffler B, Deinhardt-Emmer S. The Inflammatory Profile of Obesity and the Role on Pulmonary Bacterial and Viral Infections. Int J Mol Sci 2021; 22.
Kitazawa K, Deinhardt-Emmer S, Inomata T, Deshpande S, Sotozono C. The Transmission of SARS-CoV-2 Infection on the Ocular Surface and Prevention Strategies. Cells 2021; 10.
Kumar S, Çalışkan DM, Janowski J, Faist A, Conrad BCG, Lange J et al. Beyond Vaccines: Clinical Status of Prospective COVID-19 Therapeutics. Front Immunol 2021; 12: 752227.
Laise P, Stanifer ML, Bosker G, Sun X, Triana S, Doldan P et al. Network-based identification and pharmacological targeting of host cell master regulators induced by SARS-CoV-2 infection. bioRxiv 2021: 2021.2007.2003.451001.
Lehmann M, Allers K, Heldt C, Meinhardt J, Schmidt F, Rodriguez-Sillke Y et al. Human small intestinal infection by SARS-CoV-2 is characterized by a mucosal infiltration with activated CD8(+) T cells. Mucosal Immunol 2021; 14: 1381-1392.
Loyal L, Braun J, Henze L, Kruse B, Dingeldey M, Reimer U et al. Cross-reactive CD4(+) T cells enhance SARS-CoV-2 immune responses upon infection and vaccination. Science 2021.
Michalick L, Weidenfeld S, Grimmer B, Fatykhova D, Solymosi PD, Behrens F, Dohmen M, Brack MC, Schulz S, Thomasch E, Simmons S, Müller-Redetzky H, Suttorp N, Kurth F, Neudecker J, Toennies M, Bauer TT, Eggeling S, Corman VM, Hocke AC, Witzenrath M, Hippenstiel S, Kuebler WM. Plasma mediators in patients with severe COVID-19 cause lung endothelial barrier failure. Eur Respir J. 2021 Mar 11;57(3):2002384. doi: 10.1183/13993003.02384-2020. PMID: 33154030
Niemeyer D, Schroeder S, Friedmann K, Weege F, Trimpert J, Richter A et al. Post-entry, spike-dependent replication advantage of B.1.1.7 and B.1.617.2 over B.1 SARS-CoV-2 in an ACE2-deficient human lung cell line. bioRxiv 2021: 2021.2010.2020.465121.
Nouailles G, Wyler E, Pennitz P, Postmus D, Vladimirova D, Kazmierski J et al. Temporal omics analysis in Syrian hamsters unravel cellular effector responses to moderate COVID-19. Nat Commun 2021; 12: 4869.
Ochs M, Timm S, Elezkurtaj S, Horst D, Meinhardt J, Heppner FL et al. Collapse induration of alveoli is an ultrastructural finding in a COVID-19 patient. Eur Respir J 2021; 57.
Pietzner M, Chua RL, Wheeler E, Jechow K, Radbruch H, Trump S et al. ELF5 is a respiratory epithelial cell-specific risk gene for severe COVID-19. medRxiv 2022: 2022.2001.2017.22269283.
Ramirez Alvarez C, Kee C, Sharma AK, Thomas L, Schmidt FI, Stanifer ML et al. The endogenous cellular protease inhibitor SPINT2 controls SARS-CoV-2 viral infection and is associated to disease severity. PLOS Pathogens 2021; 17: e1009687.
Ritschel N, Radbruch H, Herden C, Schneider N, Dittmayer C, Franz J et al. [COVID-19 and the central and peripheral nervous system]. Pathologe 2021; 42: 172-182.
Schreiber A, Viemann D, Schoning J, Schloer S, Mecate Zambrano A, Brunotte L et al. The MEK1/2-inhibitor ATR-002 efficiently blocks SARS-CoV-2 propagation and alleviates pro-inflammatory cytokine/chemokine responses. Cell Mol Life Sci 2022; 79: 65.
Schroeder S, Pott F, Niemeyer D, Veith T, Richter A, Muth D et al. Interferon antagonism by SARS-CoV-2: a functional study using reverse genetics. Lancet Microbe 2021; 2: e210-e218.
Schulze J, Mache C, Balazs A, Frey D, Niemeyer D, Olze H et al. Analysis of SARS-CoV-2 replication in explant cultures of the human upper respiratory tract reveals broad tissue tropism of wild-type and B.1.1.7 variant viruses. J Infect Dis 2021.
Schuster S, Lisack J, Subota I, Zimmermann H, Reuter C, Mueller T et al. Unexpected plasticity in the life cycle of Trypanosoma brucei. Elife 2021; 10.
Stanifer ML, Boulant S. Adapting Gastrointestinal Organoids for Pathogen Infection and Single Cell Sequencing under Biosafety Level 3 (BSL-3) Conditions. JoVE 2021: e62857.
Trump S, Lukassen S, Anker MS, Chua RL, Liebig J, Thurmann L et al. Hypertension delays viral clearance and exacerbates airway hyperinflammation in patients with COVID-19. Nat Biotechnol 2021; 39: 705-716.
Wang Z, Cryar A, Lemke O, Ludwig D, Tober-Lau P, Helbig ET et al. A multiplex protein panel assay determines disease severity and is prognostic about outcome in COVID-19 patients. medRxiv 2021: 2021.2012.2003.21267253.
Wendisch D, Dietrich O, Mari T, von Stillfried S, Ibarra IL, Mittermaier M et al. SARS-CoV-2 infection triggers profibrotic macrophage responses and lung fibrosis. Cell 2021; 184: 6243-6261.e6227.
Witkowski M, Tizian C, Ferreira-Gomes M, Niemeyer D, Jones TC, Heinrich F et al. Untimely TGFβ responses in COVID-19 limit antiviral functions of NK cells. Nature 2021.
Wyler E, Adler JM, Eschke K, Alves GT, Peidli S, Pott F et al. Insights into standards of care – dexamethasone and antibodies against COVID-19 in hamster models. bioRxiv 2021: 2021.2012.2017.473180.
Wyler E, Mosbauer K, Franke V, Diag A, Gottula LT, Arsie R et al. Transcriptomic profiling of SARS-CoV-2 infected human cell lines identifies HSP90 as target for COVID-19 therapy. iScience 2021; 24: 102151.

PallPan

Andreas_M, Piechotta_V, Skoetz_N, Grummich_K, Becker_M, Joos_L, Becker_G, Meissner_W, Boehlke_C. (2021). Interventions for palliative symptom control in COVID-19 patients. Cochrane Database of Systematic Reviews 2021, Issue 8. Art. No.: CD015061.
Bausewein C., Hodiamont F., Berges N., Ullrich A., Gerlach C., Oechsle K., Pauli B., Weber J., Stiel S., Schneider N., Krumm N., Rolke R., Gebel C., Jansky M., Nauck F., Wedding U., van Oorschot B., Roch C., Werner L., Fischer M., et al. (2022). National strategy for palliative care of severely ill and dying people and their relatives in pandemics (PallPan) in Germany - study protocol of a mixed-methods project. BMC palliative care, 21(1), 10. doi.org/10.1186/s12904-021-00898-w.
Bausewein, C., & Simon, ST. (2021). Nationale Strategie für die Betreuung von schwerkranken und sterbenden Menschen und ihren Angehörigen in Pandemiezeiten (PallPan). Zenodo. http://doi.org/10.5281/zenodo.5012504
Gebel C., Kloppenburg L., Jansky M. K., Nauck F., Schade F., & Weddin, U. (2021). „Es waren Kreativität und Umdenken erforderlich.“ Auswirkungen der COVID-19 Pandemie auf die spezialisierte ambulante Palliativversorgung (SAPV). Eine bundesweite Onlinebefragung [“Creativity and a Mindset Shift were Essential.” Impact of the COVID-19 Pandemic on Specialized Palliative Home: A Nationwide Online Survey]. Gesundheitswesen(EFirst).
Gebel C., Kloppenburg L., Jansky M. K., Nauck F., Schade F., & Weddin, U. (2022). „Es waren Kreativität und Umdenken erforderlich.“ Auswirkungen der COVID-19 Pandemie auf die spezialisierte ambulante Palliativversorgung (SAPV). Eine bundesweite Onlinebefragung. Gesundheitswesen DOI: 10.1055/a-1714-8336.
Gesell D., Lehmann E., Gauder S., Wallner M., Simon ST., Bausewein C. (2021). National and international non-therapeutic recommendations for adult palliative and end-of-life care in times of pandemics: A scoping review. Palliative and Supportive Care, 1-13. doi:10.1017/S1478951521001772.
Jansky M., Schade F., Rieder N., Lohrmann D., Gebel C., et al. (2021) ‘It felt like a black hole, great uncertainty, but we have to take care for our patients’–Qualitative findings on the effects of the COVID-19 pandemic on specialist palliative home care. PLOS ONE 16(12): e0260767.
Jung N., Simon ST. (2021). Menschenwürdige Begleitung auch unter Pandemiebedingungen ein Muss! – Nationale Strategie mit 33 Handlungsempfehlungen. Zeitschrift für Palliativmedizin 2021; 22(05): 229-230. doi: 10.1055/a-1388-0543.
Oorschot et al. (2022). PallPan Richtig handeln in der Betreuung Schwerkranker und Sterbender in Pandemiezeiten. Erschienen in Der Ophthalmologe, der Onkologe, der Urologe, Forum DKG.
Oorschot et al. (2022). Interaktive Homepage für Trauernde in Pandemiezeiten. Erschienen in der Schmerz, der Nervenarzt, Forum DKG, der Urologe, der Onkologe.
Radbruch L. und Bausewein C. (2022). Covid-19: Was die Palliativmedizin leisten kann. Rheinisches Ärzteblatt (6/2022). Der Artikel ist in angepasster Form unter dem Titel „COVID-19 und Palliativversorgung“ im Forum der DKG (3/2022), DOI: 10.1007/s12312-022-01070-y erschienen, der Mitgliederzeitschrift der Deutschen Krebsgesellschaft.
Pauli B., Strupp J., Schloesser K., et al (2022). It’s like standing in front of a prison fence – Dying during the SARS-CoV2 pandemic: A qualitative study of bereaved relatives’ experiences. Palliative Medicine. doi:10.1177/02692163221076355.
Schloesser K., Simon S.T., Pauli B. et al. (2021). “Saying goodbye all alone with no close support was difficult”- Dying during the COVID-19 pandemic: an online survey among bereaved relatives about end-of-life care for patients with or without SARS-CoV2 infection. BMC Health Serv Res 21, 998 (2021). doi.org/10.1186/s12913-021-06987-z.
Schwartz J., Reuters M.C., Schallenburger M. et al. (2021). Allgemeine Palliativversorgung in Pandemiezeiten. Onkologe 27, 686–690 (2021). https://doi.org/10.1007/s00761-021-00970-3
Schwartz J., et al. (2021). Psyschische Belastung des Intensivpersonals: Kommunikationsseminare helfen. Deutsches Ärzteblatt 118 (50).
Schwartz J., Reuters M. C., Schallenburger M., Meier, S., Roch, C., Werner, L., van Oorschot, B., Neukirchen, M. (2022) Modelle guter Praxis: Alleine sterben ist ethisch nicht vertretbar. Praxis Palliative Care 54 / 2022, 29-36 (aktualisierte Version der Publikation von Schwartz et al., 2021 in Der Onkologe).
Stiel S., Weber JP., Simon ST., Bausewein C., Schneider N. (2021). PallPan: Entwicklung einer „Nationalen Strategie für Palliativversorgung in Pandemiezeiten “. pflegen: Palliativ, 2021(51), 46-48.
Stiel und Schneider (2021). Mehr Nähe am Lebensende trotz Pandemie ermöglichen – MHH untersucht im Forschungsverbund PallPan Auswirkungen auf ambulante Palliativversorgung
MHH Insight. https://doi.org/10.5281/zenodo.5012504
Tielker JM., Weber JP., Simon ST., Bausewein C., Stiel S., Schneider N. (2021) Experiences, challenges and perspectives for ensuring end-of-life patient care: A national online survey with general practitioners in Germany. PLoS ONE 16(7): e0254056. https://doi.org/10.1371/journal.pone.0254056
Weber J.P., Tielker J.M., Kamandi N. et al. (2021). Ambulante Betreuung onkologischer Patienten in palliativer Behandlungssituation und ihrer Angehörigen in der COVID-19-Pandemie. Onkologe 27, 783–789. https://doi.org/10.1007/s00761-021-00974-z
Ziegaus et al. (2021). Palliativversorgung in Pandemie zeiten im Krankenhaus Bericht über ein Teilprojekt der "Nationalen Strategie für Palliativversorgung in Pandemiezeiten (PallPan)" KU Gesundheitsmanagement, 3/2021.

RACOON (NUM 1.0)

Bernatz S, Afat S, Othman AE et al. Impact of the COVID-19 Pandemic on Radiology in Inpatient and Outpatient Care in Germany: A Nationwide Survey Regarding the First and Second Wave. Fortschr Röntgenstr 2022; 194: 70 – 82
Salg GA, Ganten MK, Bucher AM, Kenngott HG, et al. A reporting and analysis framework for structured evaluation of COVID-19 clinical and imaging data. NPJ Digit Med. 2021 Apr 12;4(1):6
Scherer J, Nolden M, Kleesiek J, Metzger J, et al. Joint Imaging Platform for Federated Clinical Data Analytics. JCO Clin Cancer Inform. 2020 Nov;4:1027-103
RACOON: Das Radiological Cooperative Network zur Beantwortung der großen Fragen in der Radiologie“. RöFo - Fortschritte auf dem Gebiet der Röntgenstrahlen und der bildgebenden Verfahren 194, Nr. 01 (Januar 2022): 95–95. https://doi.org/10.1055/a-1544-2240.
Bucher A, Kleesiek J, Kuhl CK, Antoch G, Kauczor HU, Schlemmer HP, Makowski M, Heindel W, Nikolaou K, Hamm B, Vogl T, Penzkofer T: RACOON: A nationwide radiological infrastructure of German University Radiologies for collaborative imaging research on COVID-19, Conference of the Radiological Society of North America 2021
RACOON - die Zukunft durch vernetzte Intelligenz I = Die Plattform der deutschen Radiologie im Netzwerk Universitätsmedizin, Deutscher Röntgenkongress 2021
RACOON - Die Zukunft durch vernetzte Intelligenz II: Methoden, Definitionen und Umsetzung, Deutscher Röntgenkongress 2021
RACOON - Die Zukunft durch vernetzte Intelligenz III: Innovationen und Ausblick, Deutscher Röntgenkongress 2021